,type,age_at_initial_pathologic_diagnosis,gender,race,ajcc_pathologic_tumor_stage,initial_pathologic_dx_year,tumor_status,treatment_outcome_first_course,last_contact_days_to,OS
0,ACC,23.0,FEMALE,WHITE,Stage III,2008.0,WITH TUMOR,Complete Remission/Response,2091.0,0.0
1,ACC,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2703.0,0.0
2,ACC,22.0,FEMALE,WHITE,Stage II,2010.0,WITH TUMOR,Complete Remission/Response,1352.0,0.0
3,ACC,57.0,FEMALE,WHITE,Stage II,2005.0,TUMOR FREE,Complete Remission/Response,3038.0,0.0
4,ACC,69.0,FEMALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2015.0,0.0
5,ACC,32.0,FEMALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,2110.0,0.0
6,ACC,22.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2331.0,0.0
7,ACC,49.0,MALE,WHITE,Stage IV,2009.0,TUMOR FREE,Partial Remission/Response,1497.0,0.0
8,ACC,36.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,2056.0,0.0
9,ACC,26.0,FEMALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,1194.0,0.0
10,ACC,40.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,464.0,0.0
11,ACC,26.0,FEMALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,1103.0,0.0
12,ACC,45.0,MALE,WHITE,Stage I,2002.0,TUMOR FREE,Complete Remission/Response,3688.0,0.0
13,ACC,65.0,FEMALE,WHITE,Stage II,2011.0,WITH TUMOR,Stable Disease,907.0,0.0
14,ACC,55.0,MALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,2023.0,0.0
15,ACC,47.0,MALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,2202.0,0.0
16,ACC,60.0,MALE,WHITE,Stage II,2011.0,WITH TUMOR,Progressive Disease,822.0,0.0
17,ACC,69.0,FEMALE,WHITE,Stage II,2009.0,WITH TUMOR,Progressive Disease,1029.0,0.0
18,ACC,48.0,MALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,3289.0,0.0
19,ACC,53.0,MALE,WHITE,Stage II,2005.0,TUMOR FREE,Complete Remission/Response,3465.0,0.0
20,ACC,64.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1082.0,0.0
21,ACC,56.0,FEMALE,WHITE,Stage II,2010.0,WITH TUMOR,Complete Remission/Response,1493.0,0.0
22,ACC,39.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,749.0,0.0
23,ACC,61.0,FEMALE,WHITE,Stage II,2011.0,WITH TUMOR,Progressive Disease,741.0,0.0
24,ACC,39.0,FEMALE,WHITE,Stage IV,2009.0,WITH TUMOR,Progressive Disease,1414.0,0.0
25,ACC,45.0,FEMALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2777.0,0.0
26,ACC,20.0,FEMALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2677.0,0.0
27,ACC,72.0,MALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2549.0,0.0
28,ACC,44.0,FEMALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,2895.0,0.0
29,ACC,37.0,FEMALE,WHITE,Stage II,2000.0,TUMOR FREE,Complete Remission/Response,4673.0,0.0
30,ACC,17.0,FEMALE,WHITE,Stage III,2003.0,TUMOR FREE,Complete Remission/Response,3878.0,0.0
31,ACC,55.0,FEMALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,2076.0,0.0
32,ACC,25.0,FEMALE,WHITE,Stage III,2010.0,WITH TUMOR,Progressive Disease,1364.0,0.0
33,ACC,37.0,FEMALE,WHITE,Stage II,2000.0,WITH TUMOR,Complete Remission/Response,1781.0,0.0
34,ACC,67.0,FEMALE,WHITE,Stage I,2000.0,TUMOR FREE,Complete Remission/Response,4628.0,0.0
35,ACC,48.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,967.0,0.0
36,ACC,77.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1317.0,0.0
37,ACC,60.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,861.0,0.0
38,ACC,36.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,885.0,0.0
39,ACC,53.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,871.0,0.0
40,ACC,52.0,FEMALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,719.0,0.0
41,ACC,46.0,MALE,WHITE,Stage III,2008.0,WITH TUMOR,Complete Remission/Response,1589.0,0.0
42,ACC,53.0,FEMALE,WHITE,Stage IV,2011.0,WITH TUMOR,Stable Disease,1171.0,0.0
43,ACC,51.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,756.0,0.0
44,ACC,42.0,MALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3623.0,0.0
45,ACC,27.0,FEMALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
46,ACC,44.0,FEMALE,ASIAN,Stage III,2011.0,WITH TUMOR,Complete Remission/Response,679.0,0.0
47,BLCA,69.0,MALE,WHITE,Stage III,2007.0,TUMOR FREE,Complete Remission/Response,2886.0,0.0
48,BLCA,83.0,MALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,3314.0,0.0
49,BLCA,65.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,495.0,0.0
50,BLCA,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,512.0,0.0
51,BLCA,55.0,MALE,WHITE,Stage II,2012.0,WITH TUMOR,Complete Remission/Response,840.0,0.0
52,BLCA,60.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1522.0,0.0
53,BLCA,52.0,MALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,2024.0,0.0
54,BLCA,61.0,MALE,WHITE,Stage IV,2008.0,WITH TUMOR,Progressive Disease,460.0,0.0
55,BLCA,60.0,MALE,WHITE,Stage IV,2011.0,WITH TUMOR,Complete Remission/Response,1029.0,0.0
56,BLCA,80.0,FEMALE,WHITE,Stage III,2012.0,WITH TUMOR,Complete Remission/Response,377.0,0.0
57,BLCA,54.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,522.0,0.0
58,BLCA,76.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,789.0,0.0
59,BLCA,64.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,873.0,0.0
60,BLCA,74.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,1108.0,0.0
61,BLCA,64.0,MALE,WHITE,Stage IV,2011.0,TUMOR FREE,Complete Remission/Response,864.0,0.0
62,BLCA,62.0,MALE,ASIAN,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,389.0,0.0
63,BLCA,75.0,FEMALE,ASIAN,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,382.0,0.0
64,BLCA,52.0,MALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,425.0,0.0
65,BLCA,34.0,MALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
66,BLCA,48.0,MALE,ASIAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,369.0,0.0
67,BLCA,75.0,MALE,ASIAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,398.0,0.0
68,BLCA,62.0,MALE,ASIAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,370.0,0.0
69,BLCA,41.0,MALE,ASIAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,333.0,0.0
70,BLCA,52.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
71,BLCA,42.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,368.0,0.0
72,BLCA,60.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,384.0,0.0
73,BLCA,55.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,373.0,0.0
74,BLCA,59.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,399.0,0.0
75,BLCA,67.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,365.0,0.0
76,BLCA,54.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,368.0,0.0
77,BLCA,55.0,FEMALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,345.0,0.0
78,BLCA,59.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,345.0,0.0
79,BLCA,52.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,361.0,0.0
80,BLCA,50.0,MALE,ASIAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,398.0,0.0
81,BLCA,75.0,MALE,WHITE,Stage III,2011.0,WITH TUMOR,Progressive Disease,562.0,0.0
82,BLCA,58.0,MALE,WHITE,Stage IV,2011.0,TUMOR FREE,Complete Remission/Response,158.0,0.0
83,BLCA,67.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,906.0,0.0
84,BLCA,53.0,MALE,WHITE,Stage IV,2008.0,TUMOR FREE,Complete Remission/Response,2020.0,0.0
85,BLCA,57.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,578.0,0.0
86,BLCA,72.0,MALE,WHITE,Stage III,2000.0,TUMOR FREE,Complete Remission/Response,3981.0,0.0
87,BLCA,84.0,MALE,WHITE,Stage III,2010.0,WITH TUMOR,Progressive Disease,491.0,0.0
88,BLCA,84.0,FEMALE,WHITE,Stage IV,2010.0,TUMOR FREE,Progressive Disease,536.0,0.0
89,BLCA,65.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,475.0,0.0
90,BLCA,73.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,546.0,0.0
91,BLCA,79.0,MALE,WHITE,Stage III,2001.0,TUMOR FREE,Complete Remission/Response,4343.0,0.0
92,BLCA,81.0,MALE,WHITE,Stage IV,2005.0,TUMOR FREE,Complete Remission/Response,2656.0,0.0
93,BLCA,68.0,MALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,1529.0,0.0
94,BLCA,62.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,648.0,0.0
95,BLCA,57.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,633.0,0.0
96,BLCA,67.0,FEMALE,WHITE,Stage III,2001.0,TUMOR FREE,Complete Remission/Response,4967.0,0.0
97,BLCA,78.0,FEMALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,2009.0,0.0
98,BLCA,82.0,FEMALE,ASIAN,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,1952.0,0.0
99,BLCA,70.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1621.0,0.0
100,BLCA,61.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2330.0,0.0
101,BLCA,67.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2049.0,0.0
102,BLCA,70.0,MALE,WHITE,Stage IV,2012.0,WITH TUMOR,Complete Remission/Response,477.0,0.0
103,BLCA,45.0,MALE,WHITE,Stage IV,2010.0,TUMOR FREE,Complete Remission/Response,1542.0,0.0
104,BLCA,57.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,1115.0,0.0
105,BLCA,64.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Partial Remission/Response,1582.0,0.0
106,BLCA,72.0,FEMALE,WHITE,Stage II,2013.0,TUMOR FREE,Partial Remission/Response,457.0,0.0
107,BLCA,68.0,MALE,WHITE,Stage IV,2001.0,WITH TUMOR,Stable Disease,5041.0,0.0
108,BLCA,60.0,MALE,WHITE,Stage III,2000.0,TUMOR FREE,Complete Remission/Response,5050.0,0.0
109,BLCA,63.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,572.0,0.0
110,BLCA,64.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,578.0,0.0
111,BLCA,63.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Progressive Disease,467.0,0.0
112,BLCA,71.0,MALE,WHITE,Stage II,2013.0,WITH TUMOR,Stable Disease,415.0,0.0
113,BLCA,75.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1708.0,0.0
114,BLCA,64.0,FEMALE,WHITE,Stage II,2013.0,WITH TUMOR,Complete Remission/Response,366.0,0.0
115,BLCA,61.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Stable Disease,618.0,0.0
116,BLCA,61.0,FEMALE,WHITE,Stage IV,2008.0,TUMOR FREE,Complete Remission/Response,1326.0,0.0
117,BLCA,57.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,163.0,0.0
118,BLCA,72.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,508.0,0.0
119,BLCA,81.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,820.0,0.0
120,BLCA,55.0,MALE,ASIAN,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,798.0,0.0
121,BLCA,75.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,731.0,0.0
122,BLCA,37.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,750.0,0.0
123,BLCA,73.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,28.0,0.0
124,BLCA,44.0,MALE,WHITE,Stage IV,2013.0,WITH TUMOR,Stable Disease,37.0,0.0
125,BLCA,63.0,MALE,ASIAN,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,416.0,0.0
126,BLCA,66.0,MALE,ASIAN,Stage III,2013.0,WITH TUMOR,Progressive Disease,428.0,0.0
127,BLCA,64.0,MALE,ASIAN,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,394.0,0.0
128,BLCA,52.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,466.0,0.0
129,BLCA,59.0,MALE,ASIAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,13.0,0.0
130,BLCA,56.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,384.0,0.0
131,BLCA,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,851.0,0.0
132,BLCA,60.0,MALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1845.0,0.0
133,BLCA,79.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Progressive Disease,887.0,0.0
134,BLCA,60.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,783.0,0.0
135,BLCA,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,832.0,0.0
136,BLCA,71.0,FEMALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,455.0,0.0
137,BLCA,70.0,MALE,WHITE,Stage IV,2012.0,WITH TUMOR,Complete Remission/Response,636.0,0.0
138,BLCA,84.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,110.0,0.0
139,BLCA,57.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,813.0,0.0
140,BLCA,68.0,MALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,1639.0,0.0
141,BLCA,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,588.0,0.0
142,BLCA,63.0,FEMALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,251.0,0.0
143,BLCA,61.0,FEMALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,1792.0,0.0
144,BLCA,69.0,MALE,ASIAN,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,82.0,0.0
145,BLCA,58.0,MALE,WHITE,Stage IV,2009.0,TUMOR FREE,Complete Remission/Response,1912.0,0.0
146,BLCA,82.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,572.0,0.0
147,BLCA,79.0,FEMALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,187.0,0.0
148,BLCA,60.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,330.0,0.0
149,BLCA,76.0,MALE,WHITE,Stage IV,2010.0,TUMOR FREE,Complete Remission/Response,945.0,0.0
150,BLCA,73.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,524.0,0.0
151,BLCA,76.0,MALE,WHITE,Stage IV,2013.0,TUMOR FREE,Complete Remission/Response,337.0,0.0
152,BLCA,50.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Partial Remission/Response,1884.0,0.0
153,BLCA,56.0,FEMALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1460.0,0.0
154,BLCA,57.0,MALE,WHITE,Stage II,2010.0,WITH TUMOR,Stable Disease,485.0,0.0
155,BLCA,66.0,MALE,ASIAN,Stage II,2012.0,WITH TUMOR,Stable Disease,536.0,0.0
156,BLCA,75.0,FEMALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,2008.0,0.0
157,BLCA,60.0,MALE,WHITE,Stage IV,2009.0,TUMOR FREE,Complete Remission/Response,2139.0,0.0
158,BLCA,77.0,MALE,WHITE,Stage IV,2012.0,TUMOR FREE,Partial Remission/Response,893.0,0.0
159,BLCA,79.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,481.0,0.0
160,BLCA,54.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,582.0,0.0
161,BLCA,59.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,484.0,0.0
162,BLCA,83.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,428.0,0.0
163,BLCA,80.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,540.0,0.0
164,BLCA,61.0,MALE,WHITE,Stage IV,2012.0,TUMOR FREE,Complete Remission/Response,758.0,0.0
165,BLCA,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,2013.0,TUMOR FREE,Complete Remission/Response,423.0,0.0
166,BLCA,53.0,FEMALE,WHITE,Stage IV,2011.0,WITH TUMOR,Progressive Disease,812.0,0.0
167,BLCA,54.0,FEMALE,WHITE,Stage II,2011.0,WITH TUMOR,Progressive Disease,638.0,0.0
168,BLCA,64.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,67.0,0.0
169,BLCA,86.0,FEMALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,224.0,0.0
170,BLCA,72.0,MALE,WHITE,Stage III,2012.0,WITH TUMOR,Stable Disease,997.0,0.0
171,BLCA,66.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,610.0,0.0
172,BLCA,62.0,MALE,WHITE,Stage II,2013.0,WITH TUMOR,Progressive Disease,480.0,0.0
173,BLCA,74.0,MALE,WHITE,Stage IV,2012.0,WITH TUMOR,Progressive Disease,1003.0,0.0
174,BLCA,74.0,MALE,WHITE,Stage II,2011.0,WITH TUMOR,Stable Disease,649.0,0.0
175,BLCA,59.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,581.0,0.0
176,BLCA,55.0,MALE,WHITE,Stage IV,2011.0,WITH TUMOR,Stable Disease,603.0,0.0
177,BLCA,47.0,MALE,WHITE,Stage III,2011.0,WITH TUMOR,Complete Remission/Response,1110.0,0.0
178,BLCA,56.0,FEMALE,WHITE,Stage IV,2012.0,WITH TUMOR,Stable Disease,832.0,0.0
179,BLCA,77.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,580.0,0.0
180,BLCA,54.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,691.0,0.0
181,BLCA,53.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,46.0,0.0
182,BLCA,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IV,2010.0,WITH TUMOR,Complete Remission/Response,590.0,0.0
183,BLCA,66.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,761.0,0.0
184,BLCA,59.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,842.0,0.0
185,BLCA,69.0,MALE,WHITE,Stage III,2012.0,WITH TUMOR,Progressive Disease,276.0,0.0
186,BLCA,75.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,539.0,0.0
187,BLCA,75.0,FEMALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,55.0,0.0
188,BLCA,64.0,MALE,WHITE,Stage IV,2013.0,TUMOR FREE,Complete Remission/Response,469.0,0.0
189,BLCA,77.0,MALE,WHITE,Stage IV,2013.0,WITH TUMOR,Partial Remission/Response,495.0,0.0
190,BLCA,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1604.0,0.0
191,BLCA,76.0,MALE,WHITE,Stage IV,2011.0,WITH TUMOR,Stable Disease,1094.0,0.0
192,BLCA,80.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,1350.0,0.0
193,BLCA,87.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,35.0,0.0
194,BLCA,78.0,MALE,WHITE,Stage IV,2012.0,TUMOR FREE,Complete Remission/Response,466.0,0.0
195,BLCA,56.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,474.0,0.0
196,BLCA,69.0,FEMALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,641.0,0.0
197,BLCA,75.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,410.0,0.0
198,BLCA,70.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,372.0,0.0
199,BLCA,70.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,433.0,0.0
200,BLCA,46.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,503.0,0.0
201,BLCA,66.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1186.0,0.0
202,BLCA,77.0,MALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,2964.0,0.0
203,BLCA,47.0,MALE,WHITE,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3817.0,0.0
204,BLCA,73.0,FEMALE,ASIAN,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2423.0,0.0
205,BLCA,76.0,MALE,WHITE,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,1048.0,0.0
206,BLCA,60.0,FEMALE,WHITE,Stage IV,2006.0,WITH TUMOR,Progressive Disease,640.0,0.0
207,BLCA,68.0,MALE,WHITE,Stage III,2007.0,TUMOR FREE,Complete Remission/Response,799.0,0.0
208,BLCA,78.0,FEMALE,WHITE,Stage IV,2008.0,TUMOR FREE,Complete Remission/Response,2027.0,0.0
209,BLCA,49.0,MALE,WHITE,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3364.0,0.0
210,BLCA,59.0,FEMALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2177.0,0.0
211,BLCA,48.0,MALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,2790.0,0.0
212,BLCA,78.0,MALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,3011.0,0.0
213,BLCA,76.0,MALE,WHITE,Stage IV,2007.0,TUMOR FREE,Complete Remission/Response,2625.0,0.0
214,BLCA,61.0,FEMALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,2293.0,0.0
215,BLCA,78.0,FEMALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,573.0,0.0
216,BLCA,71.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,293.0,0.0
217,BLCA,81.0,MALE,WHITE,Stage IV,2013.0,WITH TUMOR,Complete Remission/Response,773.0,0.0
218,BLCA,75.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,642.0,0.0
219,BLCA,83.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,921.0,0.0
220,BLCA,59.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1090.0,0.0
221,BLCA,76.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,665.0,0.0
222,BLCA,77.0,MALE,WHITE,Stage III,2007.0,TUMOR FREE,Complete Remission/Response,2868.0,0.0
223,BLCA,74.0,MALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1949.0,0.0
224,BLCA,70.0,FEMALE,WHITE,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,1786.0,0.0
225,BLCA,61.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2703.0,0.0
226,BLCA,70.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1455.0,0.0
227,BLCA,66.0,MALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,1806.0,0.0
228,BLCA,56.0,MALE,WHITE,Stage II,2009.0,WITH TUMOR,Complete Remission/Response,2044.0,0.0
229,BLCA,69.0,FEMALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1714.0,0.0
230,BLCA,60.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1761.0,0.0
231,BLCA,61.0,FEMALE,WHITE,Stage IV,2010.0,TUMOR FREE,Complete Remission/Response,1649.0,0.0
232,BLCA,60.0,FEMALE,WHITE,Stage IV,2012.0,WITH TUMOR,Stable Disease,897.0,0.0
233,BLCA,65.0,MALE,WHITE,Stage IV,2013.0,TUMOR FREE,Complete Remission/Response,372.0,0.0
234,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,475.0,0.0
235,COAD,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2013.0,WITH TUMOR,Stable Disease,146.0,0.0
236,COAD,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,385.0,0.0
237,COAD,76.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2011.0,WITH TUMOR,Progressive Disease,1200.0,0.0
238,COAD,82.0,FEMALE,WHITE,Stage IIIB,2009.0,TUMOR FREE,Complete Remission/Response,1419.0,0.0
239,COAD,71.0,MALE,WHITE,Stage IV,2009.0,TUMOR FREE,Complete Remission/Response,1331.0,0.0
240,COAD,78.0,MALE,WHITE,Stage IIA,2009.0,TUMOR FREE,Complete Remission/Response,1321.0,0.0
241,COAD,43.0,FEMALE,WHITE,Stage IIIB,2009.0,TUMOR FREE,Complete Remission/Response,1286.0,0.0
242,COAD,73.0,FEMALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,1366.0,0.0
243,COAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1068.0,0.0
244,COAD,73.0,FEMALE,WHITE,Stage IIA,2009.0,TUMOR FREE,Complete Remission/Response,1387.0,0.0
245,COAD,62.0,MALE,WHITE,Stage IIA,2009.0,TUMOR FREE,Complete Remission/Response,1111.0,0.0
246,COAD,57.0,FEMALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,987.0,0.0
247,COAD,74.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1001.0,0.0
248,COAD,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,962.0,0.0
249,COAD,82.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,926.0,0.0
250,COAD,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,2010.0,TUMOR FREE,Complete Remission/Response,888.0,0.0
251,COAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1020.0,0.0
252,COAD,78.0,MALE,WHITE,Stage IIC,2010.0,WITH TUMOR,Complete Remission/Response,995.0,0.0
253,COAD,40.0,FEMALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,887.0,0.0
254,COAD,55.0,MALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,824.0,0.0
255,COAD,62.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,734.0,0.0
256,COAD,56.0,FEMALE,WHITE,Stage IVA,2011.0,WITH TUMOR,Complete Remission/Response,763.0,0.0
257,COAD,66.0,MALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,735.0,0.0
258,COAD,82.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,742.0,0.0
259,COAD,65.0,FEMALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,726.0,0.0
260,COAD,74.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,612.0,0.0
261,COAD,43.0,MALE,WHITE,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,598.0,0.0
262,COAD,82.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,617.0,0.0
263,COAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2013.0,TUMOR FREE,Complete Remission/Response,293.0,0.0
264,COAD,67.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,370.0,0.0
265,COAD,81.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,650.0,0.0
266,COAD,84.0,MALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,763.0,0.0
267,COAD,62.0,MALE,WHITE,Stage IIIC,2011.0,WITH TUMOR,Complete Remission/Response,805.0,0.0
268,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,500.0,0.0
269,COAD,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1004.0,0.0
270,COAD,60.0,MALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,652.0,0.0
271,COAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,542.0,0.0
272,COAD,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,WITH TUMOR,Complete Remission/Response,525.0,0.0
273,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,543.0,0.0
274,COAD,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,588.0,0.0
275,COAD,44.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,573.0,0.0
276,COAD,47.0,FEMALE,WHITE,Stage IIIB,2006.0,TUMOR FREE,Complete Remission/Response,3324.0,0.0
277,COAD,51.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2310.0,0.0
278,COAD,79.0,FEMALE,WHITE,Stage IIA,2004.0,TUMOR FREE,Complete Remission/Response,3247.0,0.0
279,COAD,51.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2683.0,0.0
280,COAD,42.0,FEMALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,386.0,0.0
281,COAD,45.0,MALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,376.0,0.0
282,COAD,54.0,FEMALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
283,COAD,52.0,FEMALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,377.0,0.0
284,COAD,56.0,MALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
285,COAD,63.0,MALE,ASIAN,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
286,COAD,65.0,MALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,371.0,0.0
287,COAD,57.0,MALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,388.0,0.0
288,COAD,77.0,MALE,ASIAN,Stage IIA,2011.0,WITH TUMOR,Progressive Disease,435.0,0.0
289,COAD,46.0,FEMALE,WHITE,Stage IIIB,2003.0,WITH TUMOR,Stable Disease,534.0,0.0
290,COAD,45.0,FEMALE,WHITE,Stage III,2002.0,TUMOR FREE,Complete Remission/Response,4502.0,0.0
291,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2008.0,TUMOR FREE,Complete Remission/Response,2599.0,0.0
292,COAD,58.0,FEMALE,WHITE,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,1561.0,0.0
293,COAD,87.0,FEMALE,WHITE,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,2523.0,0.0
294,COAD,69.0,MALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,701.0,0.0
295,COAD,69.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,609.0,0.0
296,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,1126.0,0.0
297,COAD,53.0,MALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,792.0,0.0
298,COAD,34.0,FEMALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,244.0,0.0
299,COAD,62.0,MALE,WHITE,Stage IIIB,2009.0,TUMOR FREE,Complete Remission/Response,822.0,0.0
300,COAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,396.0,0.0
301,COAD,82.0,FEMALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,884.0,0.0
302,COAD,73.0,MALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1706.0,0.0
303,COAD,63.0,MALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,1701.0,0.0
304,COAD,62.0,FEMALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1316.0,0.0
305,COAD,51.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1087.0,0.0
306,COAD,60.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1087.0,0.0
307,COAD,64.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1456.0,0.0
308,COAD,58.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1047.0,0.0
309,COAD,59.0,FEMALE,WHITE,Stage I,2011.0,WITH TUMOR,Complete Remission/Response,1260.0,0.0
310,COAD,51.0,FEMALE,WHITE,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,1309.0,0.0
311,COAD,54.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1024.0,0.0
312,COAD,77.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,16.0,0.0
313,COAD,70.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1442.0,0.0
314,COAD,45.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1074.0,0.0
315,COAD,49.0,FEMALE,WHITE,Stage III,2002.0,TUMOR FREE,Complete Remission/Response,4051.0,0.0
316,COAD,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2007.0,TUMOR FREE,Complete Remission/Response,2600.0,0.0
317,COAD,69.0,MALE,WHITE,Stage IIIB,2008.0,TUMOR FREE,Complete Remission/Response,1935.0,0.0
318,COAD,66.0,MALE,WHITE,Stage IV,2008.0,TUMOR FREE,Complete Remission/Response,1883.0,0.0
319,COAD,84.0,MALE,WHITE,Stage IIA,2007.0,TUMOR FREE,Complete Remission/Response,2275.0,0.0
320,COAD,78.0,MALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,2424.0,0.0
321,COAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,553.0,0.0
322,COAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,588.0,0.0
323,COAD,90.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,588.0,0.0
324,COAD,71.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,2013.0,WITH TUMOR,Progressive Disease,476.0,0.0
325,COAD,53.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2013.0,WITH TUMOR,Partial Remission/Response,543.0,0.0
326,COAD,64.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,1301.0,0.0
327,COAD,55.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,896.0,0.0
328,COAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1003.0,0.0
329,COAD,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,952.0,0.0
330,COAD,84.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,666.0,0.0
331,COAD,51.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2011.0,WITH TUMOR,Partial Remission/Response,1177.0,0.0
332,COAD,44.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,2010.0,WITH TUMOR,Complete Remission/Response,1829.0,0.0
333,COAD,82.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2013.0,WITH TUMOR,Complete Remission/Response,362.0,0.0
334,COAD,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,2130.0,0.0
335,ESCA,59.0,MALE,WHITE,Stage IIB,2013.0,WITH TUMOR,Complete Remission/Response,234.0,0.0
336,ESCA,69.0,FEMALE,WHITE,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,477.0,0.0
337,ESCA,51.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1012.0,0.0
338,ESCA,54.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1071.0,0.0
339,ESCA,53.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,632.0,0.0
340,ESCA,61.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,80.0,0.0
341,ESCA,62.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Stable Disease,612.0,0.0
342,ESCA,63.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,518.0,0.0
343,ESCA,69.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,712.0,0.0
344,ESCA,50.0,FEMALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Complete Remission/Response,452.0,0.0
345,ESCA,36.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,441.0,0.0
346,ESCA,58.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,370.0,0.0
347,ESCA,56.0,MALE,WHITE,Stage I,2003.0,TUMOR FREE,Complete Remission/Response,3714.0,0.0
348,ESCA,77.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1837.0,0.0
349,ESCA,51.0,FEMALE,ASIAN,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,2069.0,0.0
350,ESCA,53.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Progressive Disease,1441.0,0.0
351,ESCA,75.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Complete Remission/Response,1060.0,0.0
352,ESCA,77.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Stable Disease,660.0,0.0
353,ESCA,47.0,MALE,ASIAN,Stage IIIB,2011.0,WITH TUMOR,Complete Remission/Response,705.0,0.0
354,ESCA,61.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Stable Disease,767.0,0.0
355,ESCA,58.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,731.0,0.0
356,ESCA,82.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,191.0,0.0
357,ESCA,74.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,920.0,0.0
358,ESCA,71.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,992.0,0.0
359,ESCA,79.0,MALE,WHITE,Stage IIIC,2012.0,WITH TUMOR,Stable Disease,608.0,0.0
360,ESCA,70.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,639.0,0.0
361,ESCA,84.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,471.0,0.0
362,ESCA,86.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,694.0,0.0
363,ESCA,62.0,MALE,WHITE,Stage IIIC,2013.0,TUMOR FREE,Complete Remission/Response,315.0,0.0
364,ESCA,62.0,MALE,ASIAN,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,385.0,0.0
365,ESCA,50.0,MALE,ASIAN,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,378.0,0.0
366,ESCA,47.0,MALE,ASIAN,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,408.0,0.0
367,ESCA,71.0,MALE,ASIAN,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,375.0,0.0
368,ESCA,46.0,MALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,407.0,0.0
369,ESCA,59.0,MALE,ASIAN,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,400.0,0.0
370,ESCA,62.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,467.0,0.0
371,ESCA,49.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
372,ESCA,73.0,MALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,403.0,0.0
373,ESCA,44.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,384.0,0.0
374,ESCA,77.0,MALE,ASIAN,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,379.0,0.0
375,ESCA,60.0,MALE,ASIAN,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,383.0,0.0
376,ESCA,57.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,380.0,0.0
377,ESCA,61.0,MALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,388.0,0.0
378,ESCA,36.0,MALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
379,ESCA,65.0,MALE,ASIAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,391.0,0.0
380,ESCA,52.0,MALE,ASIAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,472.0,0.0
381,ESCA,46.0,MALE,ASIAN,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,375.0,0.0
382,ESCA,57.0,MALE,ASIAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,402.0,0.0
383,ESCA,54.0,MALE,ASIAN,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,375.0,0.0
384,ESCA,46.0,MALE,ASIAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,768.0,0.0
385,ESCA,58.0,MALE,ASIAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,320.0,0.0
386,ESCA,59.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,365.0,0.0
387,ESCA,72.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,372.0,0.0
388,ESCA,50.0,MALE,ASIAN,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,366.0,0.0
389,ESCA,49.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,401.0,0.0
390,ESCA,56.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,375.0,0.0
391,ESCA,52.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,407.0,0.0
392,ESCA,67.0,FEMALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,401.0,0.0
393,ESCA,60.0,FEMALE,ASIAN,Stage IIA,2013.0,WITH TUMOR,Complete Remission/Response,366.0,0.0
394,ESCA,62.0,MALE,ASIAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,391.0,0.0
395,ESCA,70.0,MALE,ASIAN,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,373.0,0.0
396,ESCA,61.0,MALE,WHITE,Stage IIIB,2013.0,TUMOR FREE,Complete Remission/Response,238.0,0.0
397,ESCA,76.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Progressive Disease,609.0,0.0
398,ESCA,51.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,620.0,0.0
399,ESCA,49.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,785.0,0.0
400,ESCA,51.0,MALE,WHITE,Stage IIIB,2013.0,TUMOR FREE,Progressive Disease,824.0,0.0
401,ESCA,44.0,FEMALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,1025.0,0.0
402,ESCA,60.0,MALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,1590.0,0.0
403,ESCA,51.0,FEMALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Complete Remission/Response,549.0,0.0
404,ESCA,63.0,FEMALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1254.0,0.0
405,ESCA,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,437.0,0.0
406,ESCA,53.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,104.0,0.0
407,ESCA,57.0,MALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Complete Remission/Response,64.0,0.0
408,ESCA,53.0,MALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Complete Remission/Response,40.0,0.0
409,ESCA,57.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,81.0,0.0
410,HNSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,102.0,0.0
411,HNSC,72.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,722.0,0.0
412,HNSC,56.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1288.0,0.0
413,HNSC,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,520.0,0.0
414,HNSC,58.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,725.0,0.0
415,HNSC,62.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,644.0,0.0
416,HNSC,28.0,MALE,WHITE,Stage IVA,2011.0,WITH TUMOR,Progressive Disease,122.0,0.0
417,HNSC,61.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1273.0,0.0
418,HNSC,46.0,MALE,WHITE,Stage II,2011.0,WITH TUMOR,Complete Remission/Response,918.0,0.0
419,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2012.0,WITH TUMOR,Complete Remission/Response,850.0,0.0
420,HNSC,41.0,FEMALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,351.0,0.0
421,HNSC,24.0,FEMALE,WHITE,Stage I,2012.0,WITH TUMOR,Complete Remission/Response,216.0,0.0
422,HNSC,70.0,FEMALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,440.0,0.0
423,HNSC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVB,2013.0,TUMOR FREE,Complete Remission/Response,499.0,0.0
424,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2008.0,WITH TUMOR,Partial Remission/Response,187.0,0.0
425,HNSC,48.0,MALE,WHITE,Stage IVA,2003.0,TUMOR FREE,Complete Remission/Response,3221.0,0.0
426,HNSC,52.0,MALE,WHITE,Stage IVA,2004.0,WITH TUMOR,Progressive Disease,278.0,0.0
427,HNSC,66.0,MALE,WHITE,Stage IVA,2010.0,WITH TUMOR,Stable Disease,134.0,0.0
428,HNSC,50.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,559.0,0.0
429,HNSC,56.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,682.0,0.0
430,HNSC,67.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1117.0,0.0
431,HNSC,43.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1025.0,0.0
432,HNSC,61.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1527.0,0.0
433,HNSC,58.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,2016.0,0.0
434,HNSC,64.0,FEMALE,WHITE,Stage IVA,2011.0,WITH TUMOR,Complete Remission/Response,750.0,0.0
435,HNSC,63.0,MALE,ASIAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1168.0,0.0
436,HNSC,69.0,FEMALE,WHITE,Stage IVA,2005.0,TUMOR FREE,Complete Remission/Response,2161.0,0.0
437,HNSC,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2010.0,WITH TUMOR,Progressive Disease,624.0,0.0
438,HNSC,47.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,782.0,0.0
439,HNSC,65.0,MALE,WHITE,Stage IVA,2012.0,WITH TUMOR,Complete Remission/Response,827.0,0.0
440,HNSC,52.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,393.0,0.0
441,HNSC,45.0,FEMALE,ASIAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,386.0,0.0
442,HNSC,61.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1483.0,0.0
443,HNSC,67.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1699.0,0.0
444,HNSC,60.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1157.0,0.0
445,HNSC,56.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1560.0,0.0
446,HNSC,56.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1724.0,0.0
447,HNSC,73.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,392.0,0.0
448,HNSC,62.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,817.0,0.0
449,HNSC,61.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1586.0,0.0
450,HNSC,70.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1690.0,0.0
451,HNSC,52.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1737.0,0.0
452,HNSC,19.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,625.0,0.0
453,HNSC,75.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,2239.0,0.0
454,HNSC,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1278.0,0.0
455,HNSC,56.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1409.0,0.0
456,HNSC,68.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,2169.0,0.0
457,HNSC,55.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1584.0,0.0
458,HNSC,53.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1523.0,0.0
459,HNSC,57.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,933.0,0.0
460,HNSC,66.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1460.0,0.0
461,HNSC,64.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1443.0,0.0
462,HNSC,61.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1038.0,0.0
463,HNSC,73.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1584.0,0.0
464,HNSC,47.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,318.0,0.0
465,HNSC,61.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1066.0,0.0
466,HNSC,67.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1183.0,0.0
467,HNSC,60.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,717.0,0.0
468,HNSC,71.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,904.0,0.0
469,HNSC,60.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,225.0,0.0
470,HNSC,50.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,964.0,0.0
471,HNSC,59.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,679.0,0.0
472,HNSC,46.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,504.0,0.0
473,HNSC,47.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,367.0,0.0
474,HNSC,57.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,713.0,0.0
475,HNSC,59.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,603.0,0.0
476,HNSC,61.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,742.0,0.0
477,HNSC,59.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,635.0,0.0
478,HNSC,40.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,594.0,0.0
479,HNSC,82.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1466.0,0.0
480,HNSC,59.0,MALE,WHITE,Stage III,2007.0,TUMOR FREE,Complete Remission/Response,1593.0,0.0
481,HNSC,61.0,FEMALE,ASIAN,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,1660.0,0.0
482,HNSC,46.0,FEMALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,2143.0,0.0
483,HNSC,69.0,FEMALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,1897.0,0.0
484,HNSC,52.0,FEMALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1253.0,0.0
485,HNSC,63.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,2016.0,0.0
486,HNSC,69.0,MALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,1428.0,0.0
487,HNSC,52.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1721.0,0.0
488,HNSC,61.0,MALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1179.0,0.0
489,HNSC,59.0,FEMALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2133.0,0.0
490,HNSC,83.0,FEMALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,1973.0,0.0
491,HNSC,40.0,MALE,ASIAN,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1628.0,0.0
492,HNSC,75.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,509.0,0.0
493,HNSC,80.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1309.0,0.0
494,HNSC,77.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1274.0,0.0
495,HNSC,76.0,FEMALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1311.0,0.0
496,HNSC,51.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2359.0,0.0
497,HNSC,63.0,MALE,ASIAN,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,1353.0,0.0
498,HNSC,69.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1022.0,0.0
499,HNSC,73.0,MALE,WHITE,Stage III,2011.0,WITH TUMOR,Complete Remission/Response,950.0,0.0
500,HNSC,35.0,FEMALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,1152.0,0.0
501,HNSC,59.0,MALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,1777.0,0.0
502,HNSC,38.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,1521.0,0.0
503,HNSC,67.0,FEMALE,ASIAN,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,354.0,0.0
504,HNSC,50.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,234.0,0.0
505,HNSC,68.0,FEMALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
506,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2010.0,WITH TUMOR,Complete Remission/Response,693.0,0.0
507,HNSC,78.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,479.0,0.0
508,HNSC,66.0,MALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,1435.0,0.0
509,HNSC,60.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,1191.0,0.0
510,HNSC,52.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,1440.0,0.0
511,HNSC,54.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,1245.0,0.0
512,HNSC,45.0,MALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,759.0,0.0
513,HNSC,66.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,889.0,0.0
514,HNSC,83.0,MALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,972.0,0.0
515,HNSC,78.0,FEMALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1036.0,0.0
516,HNSC,49.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,796.0,0.0
517,HNSC,69.0,MALE,WHITE,Stage IVA,2008.0,WITH TUMOR,Complete Remission/Response,1430.0,0.0
518,HNSC,67.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1508.0,0.0
519,HNSC,36.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,913.0,0.0
520,HNSC,67.0,FEMALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1425.0,0.0
521,HNSC,26.0,MALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,993.0,0.0
522,HNSC,70.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1346.0,0.0
523,HNSC,80.0,FEMALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,930.0,0.0
524,HNSC,44.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,754.0,0.0
525,HNSC,53.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,156.0,0.0
526,HNSC,60.0,FEMALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,181.0,0.0
527,HNSC,64.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,1077.0,0.0
528,HNSC,61.0,MALE,WHITE,Stage IVA,1999.0,TUMOR FREE,Complete Remission/Response,4241.0,0.0
529,HNSC,73.0,MALE,WHITE,Stage IVA,2000.0,TUMOR FREE,Complete Remission/Response,522.0,1.0
530,HNSC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2000.0,TUMOR FREE,Complete Remission/Response,3295.0,1.0
531,HNSC,52.0,MALE,WHITE,Stage IVA,2002.0,TUMOR FREE,Complete Remission/Response,3270.0,0.0
532,HNSC,58.0,MALE,WHITE,Stage IVA,2003.0,TUMOR FREE,Complete Remission/Response,2886.0,0.0
533,HNSC,76.0,FEMALE,WHITE,Stage IVA,2004.0,TUMOR FREE,Complete Remission/Response,2327.0,0.0
534,HNSC,62.0,FEMALE,WHITE,Stage III,2005.0,TUMOR FREE,Complete Remission/Response,2641.0,0.0
535,HNSC,66.0,MALE,WHITE,Stage IVA,2007.0,TUMOR FREE,Complete Remission/Response,1840.0,0.0
536,HNSC,26.0,MALE,WHITE,Stage IVA,2007.0,TUMOR FREE,Complete Remission/Response,1315.0,0.0
537,HNSC,57.0,MALE,WHITE,Stage II,2010.0,WITH TUMOR,Complete Remission/Response,641.0,0.0
538,HNSC,73.0,FEMALE,WHITE,Stage II,2000.0,TUMOR FREE,Complete Remission/Response,4282.0,0.0
539,HNSC,39.0,MALE,WHITE,Stage II,2001.0,TUMOR FREE,Complete Remission/Response,5252.0,0.0
540,HNSC,53.0,MALE,WHITE,Stage II,2002.0,TUMOR FREE,Complete Remission/Response,3981.0,0.0
541,HNSC,67.0,MALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2347.0,0.0
542,HNSC,69.0,FEMALE,WHITE,Stage II,2007.0,TUMOR FREE,Complete Remission/Response,2727.0,0.0
543,HNSC,82.0,FEMALE,WHITE,Stage I,1998.0,WITH TUMOR,Complete Remission/Response,639.0,0.0
544,HNSC,46.0,MALE,WHITE,Stage III,1997.0,TUMOR FREE,Complete Remission/Response,5480.0,0.0
545,HNSC,48.0,MALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,1722.0,0.0
546,HNSC,65.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,852.0,0.0
547,HNSC,61.0,FEMALE,WHITE,Stage IVB,2011.0,TUMOR FREE,Complete Remission/Response,110.0,0.0
548,HNSC,69.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,646.0,0.0
549,HNSC,68.0,MALE,WHITE,Stage II,2011.0,WITH TUMOR,Complete Remission/Response,714.0,0.0
550,HNSC,58.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,606.0,0.0
551,HNSC,65.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,685.0,0.0
552,HNSC,77.0,FEMALE,WHITE,Stage I,2010.0,WITH TUMOR,Complete Remission/Response,321.0,0.0
553,HNSC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,573.0,0.0
554,HNSC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1045.0,0.0
555,HNSC,56.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,1555.0,0.0
556,HNSC,69.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,773.0,0.0
557,HNSC,59.0,MALE,WHITE,Stage III,2010.0,WITH TUMOR,Progressive Disease,292.0,0.0
558,HNSC,50.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,701.0,0.0
559,HNSC,61.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,77.0,0.0
560,HNSC,73.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,491.0,0.0
561,HNSC,55.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,568.0,0.0
562,HNSC,62.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Stable Disease,759.0,0.0
563,HNSC,52.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Stable Disease,770.0,0.0
564,HNSC,59.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,539.0,0.0
565,HNSC,61.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,376.0,0.0
566,HNSC,67.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Partial Remission/Response,875.0,0.0
567,HNSC,65.0,FEMALE,WHITE,Stage III,2012.0,WITH TUMOR,Complete Remission/Response,232.0,0.0
568,HNSC,71.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,687.0,0.0
569,HNSC,44.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Stable Disease,759.0,0.0
570,HNSC,62.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,424.0,0.0
571,HNSC,57.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,368.0,0.0
572,HNSC,50.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,389.0,0.0
573,HNSC,67.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,710.0,0.0
574,HNSC,47.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1131.0,0.0
575,HNSC,58.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,995.0,0.0
576,HNSC,48.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,658.0,0.0
577,HNSC,66.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
578,HNSC,67.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,947.0,0.0
579,HNSC,62.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,576.0,0.0
580,HNSC,54.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,759.0,0.0
581,HNSC,47.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,543.0,0.0
582,HNSC,70.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
583,HNSC,73.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,378.0,0.0
584,HNSC,75.0,FEMALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,407.0,0.0
585,HNSC,54.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,461.0,0.0
586,HNSC,50.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,458.0,0.0
587,HNSC,35.0,FEMALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,414.0,0.0
588,HNSC,65.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,642.0,0.0
589,HNSC,60.0,MALE,WHITE,Stage IVA,2011.0,WITH TUMOR,Progressive Disease,1027.0,0.0
590,HNSC,62.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,866.0,0.0
591,HNSC,69.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,783.0,0.0
592,HNSC,74.0,MALE,WHITE,Stage IVA,2011.0,WITH TUMOR,Complete Remission/Response,667.0,0.0
593,HNSC,52.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,836.0,0.0
594,HNSC,58.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,670.0,0.0
595,HNSC,61.0,FEMALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,695.0,0.0
596,HNSC,74.0,MALE,WHITE,Stage IVA,2012.0,WITH TUMOR,Complete Remission/Response,421.0,0.0
597,HNSC,56.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,210.0,0.0
598,HNSC,49.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,485.0,0.0
599,HNSC,60.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,1172.0,0.0
600,HNSC,68.0,FEMALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,441.0,0.0
601,HNSC,55.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1147.0,0.0
602,HNSC,57.0,MALE,WHITE,Stage IVA,2012.0,WITH TUMOR,Progressive Disease,360.0,0.0
603,HNSC,76.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,1138.0,0.0
604,HNSC,54.0,MALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,1021.0,0.0
605,HNSC,72.0,FEMALE,WHITE,Stage II,2012.0,WITH TUMOR,Progressive Disease,416.0,0.0
606,HNSC,61.0,FEMALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,579.0,0.0
607,HNSC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,471.0,0.0
608,HNSC,53.0,FEMALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,552.0,0.0
609,HNSC,55.0,FEMALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,586.0,0.0
610,HNSC,52.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,437.0,0.0
611,HNSC,85.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,914.0,0.0
612,HNSC,60.0,FEMALE,WHITE,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,384.0,0.0
613,HNSC,74.0,MALE,WHITE,Stage IVA,2013.0,WITH TUMOR,Progressive Disease,469.0,0.0
614,HNSC,51.0,MALE,WHITE,Stage IVA,2013.0,WITH TUMOR,Complete Remission/Response,547.0,0.0
615,HNSC,54.0,MALE,WHITE,Stage IVA,2004.0,TUMOR FREE,Complete Remission/Response,910.0,0.0
616,HNSC,49.0,MALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,1559.0,0.0
617,HNSC,50.0,MALE,WHITE,Stage IVB,2005.0,TUMOR FREE,Complete Remission/Response,1120.0,0.0
618,HNSC,47.0,FEMALE,WHITE,Stage IVA,2007.0,TUMOR FREE,Complete Remission/Response,578.0,0.0
619,HNSC,45.0,MALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,2298.0,0.0
620,HNSC,54.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,400.0,0.0
621,HNSC,60.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,645.0,0.0
622,HNSC,65.0,FEMALE,WHITE,Stage IVB,2013.0,WITH TUMOR,Progressive Disease,653.0,0.0
623,HNSC,56.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,833.0,0.0
624,HNSC,66.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,641.0,0.0
625,HNSC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,600.0,0.0
626,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,392.0,0.0
627,HNSC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,542.0,0.0
628,HNSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,466.0,0.0
629,HNSC,58.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,516.0,0.0
630,HNSC,82.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,987.0,0.0
631,HNSC,56.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,412.0,0.0
632,HNSC,51.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,403.0,0.0
633,HNSC,59.0,MALE,WHITE,Stage IVA,2013.0,TUMOR FREE,Complete Remission/Response,619.0,0.0
634,HNSC,62.0,MALE,WHITE,Stage IVA,2009.0,TUMOR FREE,Complete Remission/Response,1971.0,0.0
635,HNSC,50.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1506.0,0.0
636,HNSC,54.0,FEMALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1461.0,0.0
637,HNSC,75.0,MALE,WHITE,Stage IVA,2011.0,TUMOR FREE,Complete Remission/Response,1358.0,0.0
638,HNSC,66.0,FEMALE,WHITE,Stage IVA,2008.0,TUMOR FREE,Complete Remission/Response,2265.0,0.0
639,HNSC,80.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,1686.0,0.0
640,HNSC,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IVA,2012.0,TUMOR FREE,Complete Remission/Response,896.0,0.0
641,HNSC,69.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,443.0,0.0
642,KICH,45.0,FEMALE,WHITE,Stage II,2000.0,WITH TUMOR,Complete Remission/Response,4622.0,0.0
643,KICH,30.0,MALE,WHITE,Stage I,2011.0,WITH TUMOR,Partial Remission/Response,708.0,0.0
644,KICH,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,1366.0,0.0
645,KICH,61.0,FEMALE,WHITE,Stage I,2011.0,WITH TUMOR,Complete Remission/Response,876.0,0.0
646,KICH,57.0,MALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1520.0,0.0
647,KICH,47.0,MALE,WHITE,Stage I,2002.0,TUMOR FREE,Complete Remission/Response,3745.0,0.0
648,KICH,56.0,MALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,1553.0,0.0
649,KICH,67.0,MALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,953.0,0.0
650,KICH,36.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,106.0,0.0
651,KICH,45.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,1688.0,0.0
652,KICH,55.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,450.0,0.0
653,KICH,18.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,513.0,0.0
654,KICH,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1094.0,0.0
655,KICH,33.0,FEMALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,1961.0,0.0
656,KICH,57.0,FEMALE,ASIAN,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1506.0,0.0
657,KICH,59.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1100.0,0.0
658,KICH,55.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,1653.0,0.0
659,KICH,39.0,MALE,WHITE,Stage I,1999.0,WITH TUMOR,Complete Remission/Response,5132.0,0.0
660,KICH,50.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2108.0,0.0
661,KICH,67.0,MALE,ASIAN,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,807.0,0.0
662,KICH,53.0,MALE,WHITE,Stage I,2012.0,WITH TUMOR,Partial Remission/Response,1101.0,0.0
663,KICH,36.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,730.0,0.0
664,KICH,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,714.0,0.0
665,KICH,28.0,FEMALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,775.0,0.0
666,KICH,44.0,MALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,788.0,0.0
667,KICH,42.0,FEMALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,1983.0,0.0
668,KICH,53.0,MALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,3179.0,0.0
669,KICH,50.0,MALE,WHITE,Stage IV,2006.0,WITH TUMOR,Progressive Disease,108.0,0.0
670,KICH,38.0,FEMALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,2650.0,0.0
671,KICH,46.0,FEMALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,341.0,0.0
672,KICH,65.0,FEMALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1797.0,0.0
673,KICH,59.0,MALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3498.0,0.0
674,KICH,62.0,MALE,WHITE,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1288.0,0.0
675,KICH,42.0,FEMALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,3068.0,0.0
676,KICH,29.0,MALE,WHITE,Stage III,2005.0,TUMOR FREE,Complete Remission/Response,3056.0,0.0
677,KICH,17.0,FEMALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,3145.0,0.0
678,KICH,42.0,MALE,WHITE,Stage II,2005.0,TUMOR FREE,Complete Remission/Response,2820.0,0.0
679,KICH,69.0,MALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3180.0,0.0
680,KICH,58.0,MALE,WHITE,Stage I,2004.0,TUMOR FREE,Complete Remission/Response,3958.0,0.0
681,KICH,46.0,MALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,3038.0,0.0
682,KICH,50.0,FEMALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,3212.0,0.0
683,KICH,44.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2939.0,0.0
684,KICH,41.0,MALE,WHITE,Stage III,2007.0,TUMOR FREE,Complete Remission/Response,2752.0,0.0
685,KICH,30.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2815.0,0.0
686,KICH,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1069.0,0.0
687,KICH,50.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,980.0,0.0
688,KICH,66.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,959.0,0.0
689,KICH,49.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,809.0,0.0
690,KICH,40.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,22.0,0.0
691,KICH,48.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,1153.0,0.0
692,KICH,50.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,26.0,0.0
693,KICH,42.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1205.0,0.0
694,KICH,52.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,159.0,0.0
695,KICH,51.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,901.0,0.0
696,KICH,44.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,911.0,0.0
697,KICH,45.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,397.0,0.0
698,KICH,38.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,633.0,0.0
699,KICH,61.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,769.0,0.0
700,KICH,56.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,607.0,0.0
701,KICH,29.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,229.0,0.0
702,KICH,43.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,546.0,0.0
703,KICH,57.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,387.0,0.0
704,KICH,44.0,FEMALE,WHITE,Stage II,2002.0,TUMOR FREE,Complete Remission/Response,1327.0,0.0
705,KICH,58.0,MALE,WHITE,Stage I,2003.0,TUMOR FREE,Complete Remission/Response,3641.0,0.0
706,KICH,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3614.0,0.0
707,KICH,74.0,FEMALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,2238.0,0.0
708,KICH,47.0,MALE,WHITE,Stage II,2005.0,TUMOR FREE,Complete Remission/Response,3130.0,0.0
709,KICH,31.0,MALE,WHITE,Stage III,2005.0,TUMOR FREE,Complete Remission/Response,3036.0,0.0
710,KICH,40.0,MALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2440.0,0.0
711,KICH,44.0,FEMALE,WHITE,Stage IV,2005.0,TUMOR FREE,Complete Remission/Response,3109.0,0.0
712,KICH,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,1644.0,0.0
713,KICH,45.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,1266.0,0.0
714,KICH,57.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1032.0,0.0
715,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,385.0,0.0
716,KIRC,79.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1385.0,0.0
717,KIRC,75.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1624.0,0.0
718,KIRC,41.0,MALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,1886.0,0.0
719,KIRC,62.0,MALE,WHITE,Stage II,2005.0,TUMOR FREE,Complete Remission/Response,2688.0,0.0
720,KIRC,82.0,FEMALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,2504.0,0.0
721,KIRC,72.0,MALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,2270.0,0.0
722,KIRC,48.0,FEMALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,2274.0,0.0
723,KIRC,54.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1621.0,0.0
724,KIRC,46.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,1993.0,0.0
725,KIRC,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1018.0,0.0
726,KIRC,57.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,468.0,0.0
727,KIRC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,689.0,0.0
728,KIRC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,3.0,0.0
729,KIRC,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,0.0,0.0
730,KIRC,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,340.0,0.0
731,KIRC,37.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,323.0,0.0
732,KIRC,65.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,0.0,0.0
733,KIRC,65.0,MALE,WHITE,Stage I,2004.0,TUMOR FREE,Complete Remission/Response,3583.0,0.0
734,KIRC,62.0,MALE,WHITE,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3728.0,0.0
735,KIRC,54.0,FEMALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3328.0,0.0
736,KIRC,48.0,FEMALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3409.0,0.0
737,KIRC,40.0,MALE,WHITE,Stage IV,2005.0,TUMOR FREE,Progressive Disease,3331.0,0.0
738,KIRC,58.0,MALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,2865.0,0.0
739,KIRC,69.0,MALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,2392.0,0.0
740,KIRC,48.0,MALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2868.0,0.0
741,KIRC,58.0,FEMALE,WHITE,Stage II,2006.0,TUMOR FREE,Complete Remission/Response,2531.0,0.0
742,KIRC,58.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2508.0,0.0
743,KIRC,72.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2217.0,0.0
744,KIRC,75.0,FEMALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1755.0,0.0
745,KIRC,57.0,MALE,WHITE,Stage III,2010.0,WITH TUMOR,Progressive Disease,1778.0,0.0
746,KIRC,54.0,MALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,1782.0,0.0
747,KIRC,71.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,2009.0,0.0
748,KIRC,69.0,FEMALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1175.0,0.0
749,KIRC,43.0,MALE,WHITE,Stage IV,2009.0,WITH TUMOR,Progressive Disease,1604.0,0.0
750,KIRC,52.0,MALE,WHITE,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,1274.0,0.0
751,KIRC,40.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1608.0,0.0
752,KIRC,61.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1552.0,0.0
753,KIRC,72.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1169.0,0.0
754,KIRC,56.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1485.0,0.0
755,KIRC,46.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1411.0,0.0
756,KIRC,59.0,FEMALE,WHITE,Stage III,2008.0,TUMOR FREE,Complete Remission/Response,1733.0,0.0
757,KIRC,64.0,MALE,WHITE,Stage IV,2010.0,WITH TUMOR,Progressive Disease,1290.0,0.0
758,KIRC,53.0,FEMALE,WHITE,Stage I,2004.0,WITH TUMOR,Partial Remission/Response,3392.0,0.0
759,KIRC,66.0,FEMALE,WHITE,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3944.0,0.0
760,KIRC,47.0,FEMALE,WHITE,Stage I,2003.0,TUMOR FREE,Complete Remission/Response,4074.0,0.0
761,KIRC,61.0,FEMALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2150.0,0.0
762,KIRC,69.0,MALE,WHITE,Stage III,2007.0,WITH TUMOR,Complete Remission/Response,2609.0,0.0
763,KIRC,50.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2630.0,0.0
764,KIRC,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,3631.0,0.0
765,KIRC,53.0,MALE,WHITE,Stage I,2003.0,TUMOR FREE,Complete Remission/Response,3841.0,0.0
766,KIRC,77.0,MALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,1790.0,0.0
767,KIRC,65.0,MALE,WHITE,Stage III,2007.0,TUMOR FREE,Complete Remission/Response,2461.0,0.0
768,KIRC,71.0,MALE,WHITE,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2172.0,0.0
769,KIRC,73.0,MALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,2246.0,0.0
770,KIRC,65.0,FEMALE,WHITE,Stage I,2002.0,TUMOR FREE,Complete Remission/Response,4537.0,0.0
771,KIRC,45.0,MALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3205.0,0.0
772,KIRC,39.0,FEMALE,WHITE,Stage I,2004.0,TUMOR FREE,Complete Remission/Response,3744.0,0.0
773,KIRC,62.0,FEMALE,WHITE,Stage III,2003.0,TUMOR FREE,Complete Remission/Response,3974.0,0.0
774,KIRC,57.0,MALE,WHITE,Stage I,2008.0,WITH TUMOR,Progressive Disease,2430.0,0.0
775,KIRC,50.0,MALE,WHITE,Stage III,2004.0,WITH TUMOR,Complete Remission/Response,3989.0,0.0
776,KIRC,75.0,FEMALE,WHITE,Stage III,2006.0,TUMOR FREE,Complete Remission/Response,2782.0,0.0
777,KIRC,53.0,MALE,WHITE,Stage I,2003.0,TUMOR FREE,Complete Remission/Response,3834.0,0.0
778,KIRC,59.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,992.0,0.0
779,KIRC,73.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1092.0,0.0
780,KIRC,83.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,972.0,0.0
781,KIRC,52.0,MALE,WHITE,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,648.0,0.0
782,KIRC,61.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,952.0,0.0
783,KIRC,56.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,963.0,0.0
784,KIRC,74.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,755.0,0.0
785,KIRC,79.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,919.0,0.0
786,KIRC,79.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,656.0,0.0
787,KIRC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,507.0,0.0
788,KIRC,65.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,155.0,0.0
789,KIRC,41.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,511.0,0.0
790,KIRC,63.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,1520.0,0.0
791,KIRC,51.0,FEMALE,WHITE,Stage III,2009.0,TUMOR FREE,Complete Remission/Response,1299.0,0.0
792,KIRC,73.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1380.0,0.0
793,KIRC,58.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,523.0,0.0
794,KIRC,70.0,FEMALE,WHITE,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,777.0,0.0
795,KIRC,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,788.0,0.0
796,KIRC,57.0,MALE,WHITE,Stage IV,2010.0,WITH TUMOR,Complete Remission/Response,1525.0,0.0
797,KIRC,56.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1218.0,0.0
798,KIRC,61.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,722.0,0.0
799,KIRC,63.0,FEMALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,822.0,0.0
800,KIRC,43.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,737.0,0.0
801,KIRC,42.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1525.0,0.0
802,KIRC,53.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,194.0,0.0
803,KIRC,71.0,MALE,WHITE,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,1476.0,0.0
804,KIRC,41.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1046.0,0.0
805,KIRC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,830.0,0.0
806,KIRC,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,909.0,0.0
807,KIRC,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,519.0,0.0
808,KIRC,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,53.0,0.0
809,KIRC,69.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,256.0,0.0
810,KIRC,48.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,150.0,0.0
811,KIRC,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,528.0,0.0
812,KIRC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,469.0,0.0
813,KIRC,54.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,495.0,0.0
814,KIRC,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,431.0,0.0
815,KIRC,60.0,FEMALE,WHITE,Stage I,2004.0,TUMOR FREE,Complete Remission/Response,3498.0,0.0
816,KIRC,49.0,FEMALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3229.0,0.0
817,KIRC,49.0,MALE,WHITE,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3480.0,0.0
818,KIRC,47.0,MALE,WHITE,Stage II,2005.0,TUMOR FREE,Complete Remission/Response,3205.0,0.0
819,KIRC,64.0,MALE,WHITE,Stage IV,2005.0,TUMOR FREE,Complete Remission/Response,3451.0,0.0
820,KIRC,72.0,MALE,WHITE,Stage IV,2005.0,TUMOR FREE,Progressive Disease,3519.0,0.0
821,KIRC,79.0,FEMALE,WHITE,Stage III,2005.0,WITH TUMOR,Complete Remission/Response,3341.0,0.0
822,KIRC,60.0,FEMALE,WHITE,Stage IV,2006.0,WITH TUMOR,Stable Disease,3302.0,0.0
823,KIRC,51.0,MALE,WHITE,Stage I,2004.0,TUMOR FREE,Complete Remission/Response,3987.0,0.0
824,KIRC,70.0,MALE,WHITE,Stage II,2004.0,WITH TUMOR,Complete Remission/Response,3936.0,0.0
825,KIRC,47.0,MALE,WHITE,Stage III,2004.0,WITH TUMOR,Complete Remission/Response,4067.0,0.0
826,KIRC,60.0,MALE,WHITE,Stage IV,2004.0,WITH TUMOR,Stable Disease,3736.0,0.0
827,KIRC,63.0,FEMALE,WHITE,Stage II,2004.0,TUMOR FREE,Complete Remission/Response,3639.0,0.0
828,KIRC,60.0,MALE,WHITE,Stage I,2003.0,TUMOR FREE,Stable Disease,3222.0,0.0
829,KIRC,73.0,MALE,WHITE,Stage I,2004.0,TUMOR FREE,Stable Disease,3146.0,0.0
830,KIRC,44.0,FEMALE,WHITE,Stage I,2004.0,TUMOR FREE,Stable Disease,2701.0,0.0
831,KIRC,40.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2008.0,WITH TUMOR,Complete Remission/Response,2004.0,0.0
832,KIRC,37.0,MALE,WHITE,Stage I,2008.0,WITH TUMOR,Complete Remission/Response,2016.0,0.0
833,KIRC,53.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,365.0,0.0
834,KIRC,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2008.0,WITH TUMOR,Stable Disease,2470.0,0.0
835,KIRC,81.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2133.0,0.0
836,KIRC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,61.0,0.0
837,KIRC,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,607.0,0.0
838,KIRC,58.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,700.0,0.0
839,KIRC,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,498.0,0.0
840,KIRC,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,356.0,0.0
841,KIRP,53.0,MALE,WHITE,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,214.0,0.0
842,KIRP,71.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2298.0,0.0
843,KIRP,71.0,FEMALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,1795.0,0.0
844,KIRP,50.0,MALE,WHITE,Stage I,2007.0,WITH TUMOR,Complete Remission/Response,2790.0,0.0
845,KIRP,77.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,2294.0,0.0
846,KIRP,59.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1728.0,0.0
847,KIRP,64.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1662.0,0.0
848,KIRP,38.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1567.0,0.0
849,KIRP,69.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1213.0,0.0
850,KIRP,50.0,MALE,WHITE,Stage III,2011.0,WITH TUMOR,Stable Disease,1186.0,0.0
851,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,1006.0,0.0
852,KIRP,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,740.0,0.0
853,KIRP,56.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,949.0,0.0
854,KIRP,63.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,893.0,0.0
855,KIRP,71.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,684.0,0.0
856,KIRP,66.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,4.0,0.0
857,KIRP,58.0,MALE,WHITE,Stage IV,2013.0,WITH TUMOR,Stable Disease,390.0,0.0
858,KIRP,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,352.0,0.0
859,KIRP,81.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,373.0,0.0
860,KIRP,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,650.0,0.0
861,KIRP,74.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,238.0,0.0
862,KIRP,61.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,506.0,0.0
863,KIRP,73.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,896.0,0.0
864,KIRP,58.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,780.0,0.0
865,KIRP,60.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,729.0,0.0
866,KIRP,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,708.0,0.0
867,KIRP,47.0,MALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,709.0,0.0
868,KIRP,71.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,597.0,0.0
869,KIRP,48.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,600.0,0.0
870,KIRP,59.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,436.0,0.0
871,KIRP,84.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
872,KIRP,71.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,516.0,0.0
873,KIRP,45.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,496.0,0.0
874,KIRP,65.0,FEMALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,479.0,0.0
875,KIRP,61.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,252.0,0.0
876,KIRP,66.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
877,KIRP,55.0,MALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,1906.0,0.0
878,KIRP,72.0,FEMALE,WHITE,Stage IV,2008.0,WITH TUMOR,Progressive Disease,2060.0,0.0
879,KIRP,73.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1251.0,0.0
880,KIRP,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,1141.0,0.0
881,KIRP,62.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,1110.0,0.0
882,KIRP,54.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,842.0,0.0
883,KIRP,43.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
884,KIRP,77.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,510.0,0.0
885,KIRP,64.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,618.0,0.0
886,KIRP,54.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,641.0,0.0
887,KIRP,52.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,1029.0,0.0
888,KIRP,59.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,883.0,0.0
889,KIRP,56.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,930.0,0.0
890,KIRP,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
891,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,309.0,0.0
892,KIRP,71.0,MALE,WHITE,Stage III,2010.0,TUMOR FREE,Complete Remission/Response,665.0,0.0
893,KIRP,59.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,671.0,0.0
894,KIRP,70.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2012.0,TUMOR FREE,Partial Remission/Response,361.0,0.0
895,KIRP,47.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,585.0,0.0
896,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,524.0,0.0
897,KIRP,40.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,5.0,0.0
898,KIRP,71.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,452.0,0.0
899,KIRP,52.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,532.0,0.0
900,KIRP,79.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,374.0,0.0
901,KIRP,38.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,1486.0,0.0
902,KIRP,43.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1240.0,0.0
903,KIRP,37.0,FEMALE,ASIAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,398.0,0.0
904,KIRP,75.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,73.0,0.0
905,KIRP,38.0,FEMALE,ASIAN,Stage IV,2013.0,TUMOR FREE,Complete Remission/Response,36.0,0.0
906,KIRP,79.0,MALE,ASIAN,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,13.0,0.0
907,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2007.0,TUMOR FREE,Complete Remission/Response,2765.0,0.0
908,KIRP,58.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2173.0,0.0
909,KIRP,83.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,786.0,0.0
910,KIRP,40.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,768.0,0.0
911,KIRP,70.0,MALE,WHITE,Stage IV,2013.0,WITH TUMOR,Stable Disease,547.0,0.0
912,KIRP,61.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,702.0,0.0
913,KIRP,62.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2453.0,0.0
914,KIRP,63.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,393.0,0.0
915,KIRP,63.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,841.0,0.0
916,KIRP,79.0,MALE,WHITE,Stage III,2012.0,TUMOR FREE,Complete Remission/Response,378.0,0.0
917,KIRP,46.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,546.0,0.0
918,KIRP,66.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,392.0,0.0
919,KIRP,69.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,341.0,0.0
920,KIRP,74.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,496.0,0.0
921,KIRP,56.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,511.0,0.0
922,KIRP,49.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,608.0,0.0
923,KIRP,60.0,FEMALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,62.0,0.0
924,KIRP,82.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,677.0,0.0
925,KIRP,50.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,649.0,0.0
926,KIRP,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,497.0,0.0
927,KIRP,63.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,376.0,0.0
928,KIRP,42.0,MALE,ASIAN,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,388.0,0.0
929,KIRP,75.0,MALE,ASIAN,Stage I,2013.0,WITH TUMOR,Complete Remission/Response,307.0,0.0
930,KIRP,85.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,560.0,0.0
931,KIRP,65.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,885.0,0.0
932,KIRP,40.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,347.0,0.0
933,KIRP,50.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1043.0,0.0
934,KIRP,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,845.0,0.0
935,KIRP,62.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,924.0,0.0
936,KIRP,66.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,841.0,0.0
937,KIRP,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
938,KIRP,62.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,536.0,0.0
939,KIRP,52.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage II,2013.0,TUMOR FREE,Complete Remission/Response,369.0,0.0
940,KIRP,54.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,947.0,0.0
941,KIRP,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2012.0,TUMOR FREE,Stable Disease,890.0,0.0
942,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage III,2004.0,TUMOR FREE,Complete Remission/Response,3035.0,0.0
943,KIRP,74.0,FEMALE,WHITE,Stage I,2004.0,TUMOR FREE,Complete Remission/Response,2649.0,0.0
944,KIRP,83.0,MALE,WHITE,Stage I,2006.0,TUMOR FREE,Complete Remission/Response,3015.0,0.0
945,KIRP,51.0,MALE,WHITE,Stage I,2005.0,TUMOR FREE,Complete Remission/Response,2816.0,0.0
946,KIRP,74.0,MALE,WHITE,Stage III,2010.0,WITH TUMOR,Complete Remission/Response,1590.0,0.0
947,KIRP,69.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1539.0,0.0
948,KIRP,69.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2400.0,0.0
949,KIRP,60.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,600.0,0.0
950,KIRP,80.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,540.0,0.0
951,KIRP,81.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,380.0,0.0
952,KIRP,51.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1457.0,0.0
953,KIRP,66.0,FEMALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1504.0,0.0
954,KIRP,57.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1357.0,0.0
955,KIRP,80.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,876.0,0.0
956,KIRP,66.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,1076.0,0.0
957,KIRP,52.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,578.0,0.0
958,KIRP,64.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1257.0,0.0
959,KIRP,48.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1266.0,0.0
960,KIRP,66.0,MALE,WHITE,Stage II,2012.0,TUMOR FREE,Complete Remission/Response,805.0,0.0
961,KIRP,67.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,1615.0,0.0
962,KIRP,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,548.0,0.0
963,KIRP,67.0,MALE,BLACK OR AFRICAN AMERICAN,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,965.0,0.0
964,KIRP,55.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,791.0,0.0
965,KIRP,60.0,FEMALE,WHITE,Stage I,2011.0,WITH TUMOR,Complete Remission/Response,1188.0,0.0
966,KIRP,57.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,567.0,0.0
967,KIRP,74.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,484.0,0.0
968,KIRP,62.0,MALE,WHITE,Stage III,2013.0,TUMOR FREE,Complete Remission/Response,567.0,0.0
969,KIRP,68.0,FEMALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,549.0,0.0
970,KIRP,69.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,475.0,0.0
971,KIRP,63.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,769.0,0.0
972,KIRP,55.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,205.0,0.0
973,KIRP,58.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,183.0,0.0
974,KIRP,61.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,Complete Remission/Response,404.0,0.0
975,LUAD,70.0,FEMALE,WHITE,Stage IIIA,2010.0,WITH TUMOR,Stable Disease,448.0,0.0
976,LUAD,80.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,133.0,0.0
977,LUAD,65.0,FEMALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,1324.0,0.0
978,LUAD,59.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1429.0,0.0
979,LUAD,74.0,FEMALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1351.0,0.0
980,LUAD,65.0,FEMALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,1367.0,0.0
981,LUAD,69.0,FEMALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,1159.0,0.0
982,LUAD,65.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Progressive Disease,1280.0,0.0
983,LUAD,66.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,1251.0,0.0
984,LUAD,55.0,FEMALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Stable Disease,1301.0,0.0
985,LUAD,74.0,FEMALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,1130.0,0.0
986,LUAD,77.0,FEMALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,1163.0,0.0
987,LUAD,33.0,FEMALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1183.0,0.0
988,LUAD,60.0,FEMALE,WHITE,Stage IA,2010.0,WITH TUMOR,Complete Remission/Response,1036.0,0.0
989,LUAD,51.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,863.0,0.0
990,LUAD,61.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,852.0,0.0
991,LUAD,58.0,MALE,WHITE,Stage IA,2011.0,WITH TUMOR,Complete Remission/Response,723.0,0.0
992,LUAD,62.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,595.0,0.0
993,LUAD,64.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,728.0,0.0
994,LUAD,67.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,845.0,0.0
995,LUAD,60.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,704.0,0.0
996,LUAD,56.0,FEMALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,658.0,0.0
997,LUAD,72.0,FEMALE,WHITE,Stage IB,2011.0,WITH TUMOR,Complete Remission/Response,705.0,0.0
998,LUAD,60.0,FEMALE,WHITE,Stage IA,2005.0,TUMOR FREE,Complete Remission/Response,2616.0,0.0
999,LUAD,59.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,2007.0,TUMOR FREE,Complete Remission/Response,1864.0,0.0
1000,LUAD,70.0,MALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,691.0,0.0
1001,LUAD,72.0,MALE,WHITE,Stage IB,2011.0,WITH TUMOR,Progressive Disease,592.0,0.0
1002,LUAD,61.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,218.0,0.0
1003,LUAD,49.0,FEMALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,1097.0,0.0
1004,LUAD,47.0,FEMALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,882.0,0.0
1005,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,2010.0,WITH TUMOR,Complete Remission/Response,889.0,0.0
1006,LUAD,52.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,719.0,0.0
1007,LUAD,54.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,385.0,0.0
1008,LUAD,73.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,285.0,0.0
1009,LUAD,58.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,260.0,0.0
1010,LUAD,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,486.0,0.0
1011,LUAD,78.0,FEMALE,WHITE,Stage IB,2012.0,WITH TUMOR,Complete Remission/Response,466.0,0.0
1012,LUAD,79.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,287.0,0.0
1013,LUAD,74.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,337.0,0.0
1014,LUAD,73.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,351.0,0.0
1015,LUAD,73.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,415.0,0.0
1016,LUAD,69.0,FEMALE,WHITE,Stage IIIA,2007.0,WITH TUMOR,Progressive Disease,157.0,1.0
1017,LUAD,79.0,FEMALE,WHITE,Stage IA,2007.0,TUMOR FREE,Complete Remission/Response,1700.0,0.0
1018,LUAD,81.0,FEMALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,1621.0,0.0
1019,LUAD,64.0,FEMALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1683.0,0.0
1020,LUAD,68.0,FEMALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,354.0,0.0
1021,LUAD,57.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,2002.0,TUMOR FREE,Complete Remission/Response,4765.0,0.0
1022,LUAD,64.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,2224.0,0.0
1023,LUAD,39.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2003.0,WITH TUMOR,Complete Remission/Response,3759.0,0.0
1024,LUAD,41.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage I,1996.0,TUMOR FREE,Complete Remission/Response,6732.0,0.0
1025,LUAD,68.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,2001.0,WITH TUMOR,Complete Remission/Response,4992.0,0.0
1026,LUAD,70.0,MALE,WHITE,Stage IA,2006.0,WITH TUMOR,Progressive Disease,3094.0,0.0
1027,LUAD,72.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1442.0,0.0
1028,LUAD,59.0,FEMALE,WHITE,Stage IIB,2003.0,WITH TUMOR,Progressive Disease,1499.0,1.0
1029,LUAD,75.0,MALE,WHITE,Stage IIB,2001.0,WITH TUMOR,Progressive Disease,1091.0,1.0
1030,LUAD,72.0,MALE,WHITE,Stage IIIB,2001.0,TUMOR FREE,Complete Remission/Response,2370.0,1.0
1031,LUAD,86.0,FEMALE,WHITE,Stage IA,2006.0,TUMOR FREE,Complete Remission/Response,653.0,1.0
1032,LUAD,55.0,FEMALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,1474.0,0.0
1033,LUAD,67.0,FEMALE,WHITE,Stage IA,2009.0,WITH TUMOR,Stable Disease,1847.0,0.0
1034,LUAD,69.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,1750.0,0.0
1035,LUAD,62.0,MALE,WHITE,Stage IA,2010.0,WITH TUMOR,Progressive Disease,1617.0,0.0
1036,LUAD,63.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1125.0,0.0
1037,LUAD,68.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Progressive Disease,1119.0,0.0
1038,LUAD,74.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,829.0,0.0
1039,LUAD,51.0,FEMALE,WHITE,Stage IIIB,2008.0,TUMOR FREE,Progressive Disease,424.0,0.0
1040,LUAD,63.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Stable Disease,1071.0,0.0
1041,LUAD,74.0,FEMALE,ASIAN,Stage IA,2004.0,TUMOR FREE,Complete Remission/Response,1479.0,0.0
1042,LUAD,55.0,MALE,ASIAN,Stage IIB,2004.0,TUMOR FREE,Complete Remission/Response,2065.0,0.0
1043,LUAD,60.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,435.0,0.0
1044,LUAD,63.0,MALE,WHITE,Stage IB,2006.0,TUMOR FREE,Complete Remission/Response,2449.0,0.0
1045,LUAD,59.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,1400.0,0.0
1046,LUAD,56.0,MALE,WHITE,Stage IA,2006.0,TUMOR FREE,Complete Remission/Response,2109.0,0.0
1047,LUAD,81.0,MALE,WHITE,Stage IIB,2005.0,TUMOR FREE,Complete Remission/Response,2823.0,0.0
1048,LUAD,58.0,FEMALE,WHITE,Stage IB,2004.0,TUMOR FREE,Complete Remission/Response,1233.0,0.0
1049,LUAD,74.0,FEMALE,WHITE,Stage IB,2004.0,TUMOR FREE,Complete Remission/Response,3261.0,0.0
1050,LUAD,77.0,MALE,WHITE,Stage IA,2006.0,TUMOR FREE,Complete Remission/Response,2137.0,0.0
1051,LUAD,70.0,FEMALE,WHITE,Stage IA,2011.0,WITH TUMOR,Complete Remission/Response,872.0,0.0
1052,LUAD,76.0,FEMALE,WHITE,Stage IIIA,2011.0,WITH TUMOR,Partial Remission/Response,609.0,0.0
1053,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,824.0,0.0
1054,LUAD,72.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,487.0,0.0
1055,LUAD,54.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,670.0,0.0
1056,LUAD,76.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,705.0,0.0
1057,LUAD,68.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,442.0,0.0
1058,LUAD,72.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,652.0,0.0
1059,LUAD,70.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,119.0,0.0
1060,LUAD,64.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,704.0,0.0
1061,LUAD,64.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,567.0,0.0
1062,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,1040.0,0.0
1063,LUAD,70.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,537.0,0.0
1064,LUAD,81.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,603.0,0.0
1065,LUAD,73.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,889.0,0.0
1066,LUAD,64.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,904.0,0.0
1067,LUAD,59.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,462.0,0.0
1068,LUAD,74.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,600.0,0.0
1069,LUAD,51.0,MALE,WHITE,Stage IV,2012.0,WITH TUMOR,Progressive Disease,541.0,0.0
1070,LUAD,60.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,476.0,0.0
1071,LUAD,69.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,547.0,0.0
1072,LUAD,87.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,515.0,0.0
1073,LUAD,76.0,FEMALE,WHITE,Stage IIA,2012.0,WITH TUMOR,Progressive Disease,599.0,0.0
1074,LUAD,56.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,888.0,0.0
1075,LUAD,73.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,977.0,0.0
1076,LUAD,73.0,FEMALE,WHITE,Stage IA,2012.0,WITH TUMOR,Complete Remission/Response,674.0,0.0
1077,LUAD,58.0,MALE,WHITE,Stage IB,2012.0,WITH TUMOR,Complete Remission/Response,534.0,0.0
1078,LUAD,54.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,478.0,0.0
1079,LUAD,62.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,440.0,0.0
1080,LUAD,53.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,418.0,0.0
1081,LUAD,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,617.0,0.0
1082,LUAD,55.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,539.0,0.0
1083,LUAD,73.0,FEMALE,WHITE,Stage IB,2012.0,WITH TUMOR,Complete Remission/Response,552.0,0.0
1084,LUAD,77.0,FEMALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Complete Remission/Response,791.0,0.0
1085,LUAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,520.0,0.0
1086,LUAD,76.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,536.0,0.0
1087,LUAD,67.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Complete Remission/Response,446.0,0.0
1088,LUAD,72.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,416.0,0.0
1089,LUAD,75.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,515.0,0.0
1090,LUAD,63.0,FEMALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,689.0,0.0
1091,LUAD,69.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,630.0,0.0
1092,LUAD,60.0,FEMALE,WHITE,Stage IIIB,2012.0,WITH TUMOR,Stable Disease,651.0,0.0
1093,LUAD,81.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,626.0,0.0
1094,LUAD,70.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,596.0,0.0
1095,LUAD,61.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,481.0,0.0
1096,LUAD,71.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,608.0,0.0
1097,LUAD,80.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,546.0,0.0
1098,LUAD,80.0,FEMALE,WHITE,Stage IIB,2009.0,WITH TUMOR,Complete Remission/Response,1216.0,0.0
1099,LUAD,70.0,FEMALE,WHITE,Stage IIB,2008.0,TUMOR FREE,Complete Remission/Response,1289.0,0.0
1100,LUAD,62.0,MALE,WHITE,Stage IIIA,2006.0,TUMOR FREE,Complete Remission/Response,2696.0,0.0
1101,LUAD,71.0,FEMALE,WHITE,Stage IIB,2007.0,TUMOR FREE,Complete Remission/Response,2067.0,0.0
1102,LUAD,78.0,FEMALE,WHITE,Stage IB,2007.0,TUMOR FREE,Complete Remission/Response,2199.0,0.0
1103,LUAD,64.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,1246.0,0.0
1104,LUAD,70.0,MALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Complete Remission/Response,910.0,0.0
1105,LUAD,58.0,MALE,WHITE,Stage IA,2005.0,TUMOR FREE,Complete Remission/Response,1728.0,0.0
1106,LUAD,58.0,FEMALE,WHITE,Stage IIIA,2007.0,TUMOR FREE,Complete Remission/Response,2488.0,0.0
1107,LUAD,63.0,MALE,WHITE,Stage IV,2007.0,TUMOR FREE,Complete Remission/Response,1126.0,0.0
1108,LUAD,60.0,MALE,WHITE,Stage IB,2004.0,TUMOR FREE,Complete Remission/Response,2676.0,0.0
1109,LUAD,60.0,MALE,WHITE,Stage IB,2008.0,WITH TUMOR,Complete Remission/Response,1305.0,0.0
1110,LUAD,61.0,MALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Stable Disease,864.0,0.0
1111,LUAD,55.0,FEMALE,WHITE,Stage IB,2007.0,TUMOR FREE,Progressive Disease,1559.0,0.0
1112,LUAD,74.0,MALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,866.0,0.0
1113,LUAD,52.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,174.0,0.0
1114,LUAD,57.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,141.0,0.0
1115,LUAD,73.0,FEMALE,WHITE,Stage IIA,2010.0,WITH TUMOR,Progressive Disease,422.0,0.0
1116,LUAD,42.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,230.0,0.0
1117,LUAD,54.0,FEMALE,WHITE,Stage IIIA,2011.0,WITH TUMOR,Progressive Disease,184.0,0.0
1118,LUAD,70.0,FEMALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,411.0,0.0
1119,LUAD,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,426.0,0.0
1120,LUAD,77.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Stable Disease,813.0,0.0
1121,LUAD,60.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,2012.0,TUMOR FREE,Stable Disease,591.0,0.0
1122,LUAD,48.0,FEMALE,ASIAN,Stage IB,2011.0,WITH TUMOR,Progressive Disease,256.0,0.0
1123,LUAD,80.0,FEMALE,WHITE,Stage IB,2004.0,TUMOR FREE,Complete Remission/Response,1600.0,1.0
1124,LUAD,66.0,MALE,WHITE,Stage IIIA,2006.0,WITH TUMOR,Progressive Disease,711.0,1.0
1125,LUAD,65.0,FEMALE,WHITE,Stage IA,2007.0,TUMOR FREE,Complete Remission/Response,2515.0,0.0
1126,LUAD,52.0,FEMALE,WHITE,Stage IV,2009.0,TUMOR FREE,Complete Remission/Response,800.0,0.0
1127,LUAD,66.0,FEMALE,AMERICAN INDIAN OR ALASKA NATIVE,Stage IIB,2009.0,WITH TUMOR,Complete Remission/Response,467.0,0.0
1128,LUAD,69.0,FEMALE,WHITE,Stage IV,2010.0,WITH TUMOR,Stable Disease,131.0,0.0
1129,LUAD,58.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,1189.0,0.0
1130,LUAD,60.0,MALE,WHITE,Stage IB,1992.0,TUMOR FREE,Complete Remission/Response,7248.0,0.0
1131,LUAD,59.0,FEMALE,WHITE,Stage IA,2009.0,TUMOR FREE,Stable Disease,824.0,0.0
1132,LUAD,73.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,179.0,0.0
1133,LUAD,66.0,MALE,WHITE,Stage IV,2011.0,WITH TUMOR,Complete Remission/Response,947.0,0.0
1134,LUAD,70.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1157.0,0.0
1135,LUAD,69.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,997.0,0.0
1136,LUAD,68.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,605.0,0.0
1137,LUAD,62.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,1072.0,0.0
1138,LUAD,61.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1148.0,0.0
1139,LUAD,63.0,FEMALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,139.0,0.0
1140,LUAD,58.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,740.0,0.0
1141,LUAD,42.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,993.0,0.0
1142,LUAD,63.0,FEMALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Complete Remission/Response,944.0,0.0
1143,LUAD,46.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,949.0,0.0
1144,LUAD,54.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,701.0,0.0
1145,LUAD,75.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,0.0,0.0
1146,LUAD,44.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,653.0,0.0
1147,LUAD,57.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,353.0,0.0
1148,LUAD,61.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,423.0,0.0
1149,LUAD,64.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,938.0,0.0
1150,LUAD,72.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,839.0,0.0
1151,LUAD,61.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,862.0,0.0
1152,LUAD,50.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,806.0,0.0
1153,LUAD,78.0,FEMALE,ASIAN,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,896.0,0.0
1154,LUAD,63.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,415.0,0.0
1155,LUAD,59.0,FEMALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,805.0,0.0
1156,LUAD,70.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,323.0,0.0
1157,LUAD,66.0,MALE,WHITE,Stage IB,2001.0,TUMOR FREE,Complete Remission/Response,310.0,0.0
1158,LUAD,81.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,79.0,0.0
1159,LUAD,52.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,417.0,0.0
1160,LUAD,59.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,372.0,0.0
1161,LUAD,62.0,FEMALE,WHITE,Stage IB,2002.0,WITH TUMOR,Progressive Disease,842.0,0.0
1162,LUAD,59.0,MALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,224.0,0.0
1163,LUAD,62.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,492.0,0.0
1164,LUAD,63.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,505.0,0.0
1165,LUAD,78.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,603.0,0.0
1166,LUAD,76.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,683.0,0.0
1167,LUAD,75.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,531.0,0.0
1168,LUAD,77.0,MALE,ASIAN,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,186.0,0.0
1169,LUAD,71.0,MALE,WHITE,Stage IV,2012.0,WITH TUMOR,Stable Disease,718.0,0.0
1170,LUAD,64.0,MALE,ASIAN,Stage IV,2012.0,WITH TUMOR,Partial Remission/Response,578.0,0.0
1171,LUAD,49.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,526.0,0.0
1172,LUAD,54.0,FEMALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Complete Remission/Response,1272.0,0.0
1173,LUAD,61.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Stable Disease,568.0,0.0
1174,LUAD,71.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Stable Disease,377.0,0.0
1175,LUAD,67.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,477.0,0.0
1176,LUAD,42.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,476.0,0.0
1177,LUAD,72.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,830.0,0.0
1178,LUAD,74.0,FEMALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Stable Disease,651.0,0.0
1179,LUAD,62.0,FEMALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Stable Disease,553.0,0.0
1180,LUAD,66.0,FEMALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Stable Disease,605.0,0.0
1181,LUAD,76.0,FEMALE,WHITE,Stage IA,2008.0,WITH TUMOR,Progressive Disease,1285.0,0.0
1182,LUAD,67.0,FEMALE,WHITE,Stage IB,2007.0,WITH TUMOR,Progressive Disease,1965.0,0.0
1183,LUAD,70.0,MALE,WHITE,Stage IB,2007.0,TUMOR FREE,Stable Disease,1932.0,0.0
1184,LUAD,58.0,FEMALE,WHITE,Stage IA,2007.0,TUMOR FREE,Complete Remission/Response,1870.0,0.0
1185,LUAD,83.0,FEMALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,775.0,0.0
1186,LUAD,65.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Stable Disease,564.0,0.0
1187,LUAD,72.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,484.0,0.0
1188,LUAD,81.0,MALE,ASIAN,Stage IV,2011.0,WITH TUMOR,Progressive Disease,568.0,0.0
1189,LUAD,75.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,545.0,0.0
1190,LUAD,55.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,551.0,0.0
1191,LUAD,72.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,435.0,0.0
1192,LUAD,55.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,626.0,0.0
1193,LUAD,81.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,614.0,0.0
1194,LUAD,60.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,652.0,0.0
1195,LUAD,52.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,601.0,0.0
1196,LUAD,66.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,624.0,0.0
1197,LUAD,69.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,540.0,0.0
1198,LUAD,83.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,634.0,0.0
1199,LUAD,45.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,568.0,0.0
1200,LUAD,74.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,629.0,0.0
1201,LUAD,74.0,FEMALE,WHITE,Stage IIIA,2010.0,WITH TUMOR,Stable Disease,747.0,0.0
1202,LUAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,1060.0,0.0
1203,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1118.0,0.0
1204,LUAD,61.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,44.0,0.0
1205,LUAD,70.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,658.0,0.0
1206,LUAD,65.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Progressive Disease,739.0,0.0
1207,LUAD,69.0,FEMALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Progressive Disease,724.0,0.0
1208,LUAD,77.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,1079.0,0.0
1209,LUAD,66.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,988.0,0.0
1210,LUAD,48.0,FEMALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,578.0,0.0
1211,LUAD,67.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,435.0,0.0
1212,LUAD,60.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,307.0,0.0
1213,LUAD,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,664.0,0.0
1214,LUAD,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,565.0,0.0
1215,LUAD,60.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,827.0,0.0
1216,LUAD,57.0,MALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,1175.0,0.0
1217,LUAD,63.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,84.0,0.0
1218,LUAD,70.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,741.0,0.0
1219,LUAD,76.0,FEMALE,WHITE,Stage IB,2008.0,TUMOR FREE,Complete Remission/Response,2248.0,0.0
1220,LUAD,50.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2007.0,TUMOR FREE,Stable Disease,2161.0,0.0
1221,LUAD,65.0,MALE,WHITE,Stage IB,2008.0,TUMOR FREE,Stable Disease,2261.0,0.0
1222,LUAD,52.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Stable Disease,50.0,0.0
1223,LUAD,69.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Stable Disease,1432.0,0.0
1224,LUAD,76.0,FEMALE,WHITE,Stage IB,2009.0,TUMOR FREE,Stable Disease,15.0,0.0
1225,LUAD,56.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Stable Disease,13.0,0.0
1226,LUAD,67.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Stable Disease,603.0,0.0
1227,LUAD,49.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,2013.0,WITH TUMOR,Stable Disease,617.0,0.0
1228,LUAD,68.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,513.0,0.0
1229,LUSC,74.0,MALE,WHITE,Stage IA,2004.0,TUMOR FREE,Complete Remission/Response,3747.0,0.0
1230,LUSC,65.0,MALE,WHITE,Stage IB,2007.0,TUMOR FREE,Complete Remission/Response,2645.0,0.0
1231,LUSC,74.0,MALE,WHITE,Stage IA,2002.0,TUMOR FREE,Complete Remission/Response,4694.0,0.0
1232,LUSC,80.0,FEMALE,WHITE,Stage IB,2008.0,TUMOR FREE,Complete Remission/Response,1268.0,0.0
1233,LUSC,64.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1032.0,0.0
1234,LUSC,65.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,2009.0,WITH TUMOR,Progressive Disease,329.0,1.0
1235,LUSC,77.0,MALE,WHITE,Stage IA,2006.0,TUMOR FREE,Complete Remission/Response,979.0,0.0
1236,LUSC,63.0,MALE,WHITE,Stage IA,2001.0,TUMOR FREE,Complete Remission/Response,1953.0,1.0
1237,LUSC,65.0,MALE,WHITE,Stage IB,2001.0,TUMOR FREE,Complete Remission/Response,802.0,1.0
1238,LUSC,80.0,MALE,WHITE,Stage IIIA,2001.0,WITH TUMOR,Partial Remission/Response,623.0,1.0
1239,LUSC,57.0,MALE,WHITE,Stage IIIA,2002.0,WITH TUMOR,Complete Remission/Response,734.0,1.0
1240,LUSC,74.0,MALE,WHITE,Stage IB,2005.0,TUMOR FREE,Complete Remission/Response,445.0,1.0
1241,LUSC,66.0,FEMALE,WHITE,Stage IA,2002.0,WITH TUMOR,Complete Remission/Response,2170.0,1.0
1242,LUSC,81.0,MALE,WHITE,Stage IB,2005.0,TUMOR FREE,Complete Remission/Response,357.0,1.0
1243,LUSC,74.0,MALE,WHITE,Stage IIA,2005.0,WITH TUMOR,Complete Remission/Response,573.0,1.0
1244,LUSC,58.0,FEMALE,WHITE,Stage IA,2001.0,WITH TUMOR,Complete Remission/Response,916.0,1.0
1245,LUSC,64.0,MALE,WHITE,Stage IA,2003.0,WITH TUMOR,Complete Remission/Response,1912.0,1.0
1246,LUSC,70.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,671.0,0.0
1247,LUSC,76.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,2001.0,TUMOR FREE,Complete Remission/Response,4068.0,0.0
1248,LUSC,68.0,MALE,WHITE,Stage IB,2007.0,TUMOR FREE,Complete Remission/Response,2419.0,0.0
1249,LUSC,80.0,MALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,1927.0,0.0
1250,LUSC,70.0,MALE,WHITE,Stage IIB,2004.0,TUMOR FREE,Complete Remission/Response,80.0,1.0
1251,LUSC,76.0,FEMALE,WHITE,Stage IA,2000.0,TUMOR FREE,Complete Remission/Response,1874.0,1.0
1252,LUSC,81.0,FEMALE,WHITE,Stage IB,1999.0,TUMOR FREE,Complete Remission/Response,958.0,1.0
1253,LUSC,76.0,MALE,WHITE,Stage IIIB,2006.0,WITH TUMOR,Complete Remission/Response,881.0,1.0
1254,LUSC,84.0,MALE,WHITE,Stage IB,1999.0,TUMOR FREE,Complete Remission/Response,1000.0,1.0
1255,LUSC,81.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIB,2004.0,WITH TUMOR,Complete Remission/Response,951.0,1.0
1256,LUSC,75.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2006.0,TUMOR FREE,Complete Remission/Response,2471.0,0.0
1257,LUSC,71.0,FEMALE,WHITE,Stage IA,2007.0,TUMOR FREE,Complete Remission/Response,2271.0,0.0
1258,LUSC,75.0,MALE,WHITE,Stage IIIA,2010.0,WITH TUMOR,Complete Remission/Response,1834.0,0.0
1259,LUSC,73.0,FEMALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,1541.0,0.0
1260,LUSC,83.0,FEMALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,1196.0,0.0
1261,LUSC,62.0,FEMALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,1180.0,0.0
1262,LUSC,71.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,804.0,0.0
1263,LUSC,80.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,1031.0,0.0
1264,LUSC,52.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,242.0,0.0
1265,LUSC,61.0,FEMALE,WHITE,Stage IV,2010.0,TUMOR FREE,Complete Remission/Response,227.0,0.0
1266,LUSC,49.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,867.0,0.0
1267,LUSC,59.0,MALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,660.0,0.0
1268,LUSC,70.0,FEMALE,WHITE,Stage IA,2002.0,TUMOR FREE,Complete Remission/Response,4053.0,0.0
1269,LUSC,44.0,MALE,WHITE,Stage IIA,2003.0,TUMOR FREE,Complete Remission/Response,3850.0,0.0
1270,LUSC,70.0,MALE,WHITE,Stage IB,2004.0,TUMOR FREE,Complete Remission/Response,3387.0,0.0
1271,LUSC,70.0,MALE,WHITE,Stage IB,2004.0,WITH TUMOR,Complete Remission/Response,2057.0,1.0
1272,LUSC,65.0,FEMALE,WHITE,Stage IIIA,2005.0,TUMOR FREE,Complete Remission/Response,2510.0,0.0
1273,LUSC,73.0,MALE,WHITE,Stage IB,2006.0,WITH TUMOR,Complete Remission/Response,3108.0,0.0
1274,LUSC,72.0,FEMALE,WHITE,Stage IA,2007.0,TUMOR FREE,Complete Remission/Response,2080.0,0.0
1275,LUSC,73.0,MALE,WHITE,Stage IB,2007.0,TUMOR FREE,Complete Remission/Response,2165.0,0.0
1276,LUSC,65.0,MALE,WHITE,Stage IIA,2007.0,TUMOR FREE,Complete Remission/Response,1690.0,0.0
1277,LUSC,76.0,MALE,WHITE,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,544.0,1.0
1278,LUSC,62.0,FEMALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,1223.0,0.0
1279,LUSC,47.0,FEMALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,1176.0,0.0
1280,LUSC,71.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1007.0,0.0
1281,LUSC,70.0,MALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,849.0,0.0
1282,LUSC,70.0,MALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,699.0,0.0
1283,LUSC,69.0,FEMALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,757.0,0.0
1284,LUSC,59.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,653.0,0.0
1285,LUSC,71.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,596.0,0.0
1286,LUSC,68.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,236.0,0.0
1287,LUSC,72.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Stable Disease,407.0,0.0
1288,LUSC,73.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,358.0,0.0
1289,LUSC,66.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,353.0,0.0
1290,LUSC,67.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,296.0,0.0
1291,LUSC,76.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,432.0,0.0
1292,LUSC,61.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,2012.0,WITH TUMOR,Complete Remission/Response,366.0,0.0
1293,LUSC,59.0,FEMALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,405.0,0.0
1294,LUSC,62.0,FEMALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,370.0,0.0
1295,LUSC,76.0,MALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,396.0,0.0
1296,LUSC,58.0,MALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,4.0,1.0
1297,LUSC,71.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,324.0,0.0
1298,LUSC,81.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,423.0,0.0
1299,LUSC,62.0,FEMALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,862.0,0.0
1300,LUSC,60.0,FEMALE,WHITE,Stage IIB,2008.0,TUMOR FREE,Complete Remission/Response,923.0,0.0
1301,LUSC,74.0,MALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,378.0,0.0
1302,LUSC,69.0,MALE,WHITE,Stage IA,2010.0,TUMOR FREE,Complete Remission/Response,555.0,0.0
1303,LUSC,77.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,666.0,0.0
1304,LUSC,79.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,608.0,0.0
1305,LUSC,84.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,925.0,0.0
1306,LUSC,83.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,601.0,0.0
1307,LUSC,58.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1011.0,0.0
1308,LUSC,80.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,455.0,0.0
1309,LUSC,73.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,106.0,0.0
1310,LUSC,72.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,105.0,0.0
1311,LUSC,55.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,818.0,0.0
1312,LUSC,79.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Stable Disease,517.0,0.0
1313,LUSC,66.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,428.0,0.0
1314,LUSC,74.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,510.0,0.0
1315,LUSC,84.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,420.0,0.0
1316,LUSC,78.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
1317,LUSC,63.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,481.0,0.0
1318,LUSC,67.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,637.0,0.0
1319,LUSC,55.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,585.0,0.0
1320,LUSC,70.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,405.0,0.0
1321,LUSC,75.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,640.0,0.0
1322,LUSC,76.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,570.0,0.0
1323,LUSC,81.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,4.0,0.0
1324,LUSC,72.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,8.0,0.0
1325,LUSC,78.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,440.0,0.0
1326,LUSC,70.0,MALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,911.0,0.0
1327,LUSC,57.0,FEMALE,WHITE,Stage IIIA,2006.0,WITH TUMOR,Complete Remission/Response,2167.0,0.0
1328,LUSC,68.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,1058.0,0.0
1329,LUSC,64.0,MALE,WHITE,Stage IIB,2006.0,TUMOR FREE,Complete Remission/Response,2589.0,0.0
1330,LUSC,73.0,MALE,WHITE,Stage IIIA,2008.0,TUMOR FREE,Complete Remission/Response,1723.0,0.0
1331,LUSC,61.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,1072.0,0.0
1332,LUSC,52.0,MALE,WHITE,Stage IB,2011.0,WITH TUMOR,Complete Remission/Response,910.0,0.0
1333,LUSC,74.0,FEMALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,642.0,0.0
1334,LUSC,58.0,MALE,WHITE,Stage IA,2003.0,TUMOR FREE,Complete Remission/Response,2820.0,0.0
1335,LUSC,64.0,FEMALE,WHITE,Stage IIB,2004.0,TUMOR FREE,Complete Remission/Response,2447.0,0.0
1336,LUSC,69.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IB,2004.0,TUMOR FREE,Complete Remission/Response,1505.0,0.0
1337,LUSC,67.0,FEMALE,WHITE,Stage IIA,2005.0,TUMOR FREE,Complete Remission/Response,2024.0,0.0
1338,LUSC,64.0,FEMALE,WHITE,Stage IB,2007.0,TUMOR FREE,Complete Remission/Response,1260.0,0.0
1339,LUSC,66.0,FEMALE,WHITE,Stage IIB,2006.0,TUMOR FREE,Complete Remission/Response,1531.0,0.0
1340,LUSC,83.0,FEMALE,WHITE,Stage IB,2007.0,TUMOR FREE,Complete Remission/Response,1297.0,0.0
1341,LUSC,73.0,MALE,WHITE,Stage IB,2008.0,TUMOR FREE,Complete Remission/Response,983.0,0.0
1342,LUSC,66.0,MALE,WHITE,Stage IIB,2008.0,TUMOR FREE,Complete Remission/Response,908.0,0.0
1343,LUSC,74.0,FEMALE,WHITE,Stage IB,2008.0,TUMOR FREE,Complete Remission/Response,1092.0,0.0
1344,LUSC,74.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,816.0,0.0
1345,LUSC,56.0,MALE,WHITE,Stage IIA,2009.0,TUMOR FREE,Complete Remission/Response,358.0,1.0
1346,LUSC,78.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Stable Disease,406.0,0.0
1347,LUSC,73.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIA,2012.0,WITH TUMOR,Stable Disease,492.0,0.0
1348,LUSC,74.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,448.0,0.0
1349,LUSC,47.0,MALE,ASIAN,Stage IIIA,2010.0,WITH TUMOR,Progressive Disease,367.0,0.0
1350,LUSC,65.0,MALE,ASIAN,Stage IIA,2010.0,WITH TUMOR,Progressive Disease,375.0,0.0
1351,LUSC,59.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1259.0,0.0
1352,LUSC,66.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,1224.0,0.0
1353,LUSC,64.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1111.0,0.0
1354,LUSC,49.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1063.0,0.0
1355,LUSC,48.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,952.0,0.0
1356,LUSC,59.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,42.0,0.0
1357,LUSC,71.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,911.0,0.0
1358,LUSC,46.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,576.0,0.0
1359,LUSC,62.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,765.0,0.0
1360,LUSC,57.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,579.0,0.0
1361,LUSC,53.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,734.0,0.0
1362,LUSC,71.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,960.0,0.0
1363,LUSC,52.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,815.0,0.0
1364,LUSC,60.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,932.0,0.0
1365,LUSC,62.0,MALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,1050.0,0.0
1366,LUSC,61.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,683.0,0.0
1367,LUSC,72.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,510.0,0.0
1368,LUSC,53.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,995.0,0.0
1369,LUSC,63.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,61.0,0.0
1370,LUSC,66.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,468.0,0.0
1371,LUSC,52.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,1113.0,0.0
1372,LUSC,49.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,1160.0,0.0
1373,LUSC,56.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,1038.0,0.0
1374,LUSC,74.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,942.0,0.0
1375,LUSC,61.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,741.0,0.0
1376,LUSC,67.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,600.0,0.0
1377,LUSC,57.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,493.0,0.0
1378,LUSC,74.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,482.0,0.0
1379,LUSC,46.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,465.0,0.0
1380,LUSC,60.0,FEMALE,ASIAN,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,910.0,0.0
1381,LUSC,63.0,MALE,ASIAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,377.0,0.0
1382,LUSC,58.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,111.0,0.0
1383,LUSC,64.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,758.0,0.0
1384,LUSC,66.0,FEMALE,WHITE,Stage IA,2011.0,WITH TUMOR,Progressive Disease,289.0,0.0
1385,LUSC,55.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,358.0,0.0
1386,LUSC,70.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,428.0,0.0
1387,LUSC,69.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,615.0,0.0
1388,LUSC,53.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,688.0,0.0
1389,LUSC,45.0,FEMALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Stable Disease,82.0,0.0
1390,LUSC,71.0,MALE,WHITE,Stage IB,2011.0,WITH TUMOR,Partial Remission/Response,106.0,0.0
1391,LUSC,52.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,122.0,0.0
1392,LUSC,74.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,70.0,0.0
1393,LUSC,73.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,640.0,0.0
1394,LUSC,80.0,MALE,WHITE,Stage IA,2011.0,WITH TUMOR,Complete Remission/Response,559.0,0.0
1395,LUSC,64.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,122.0,0.0
1396,LUSC,73.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Progressive Disease,810.0,0.0
1397,LUSC,71.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,430.0,0.0
1398,LUSC,61.0,MALE,WHITE,Stage IIA,2012.0,WITH TUMOR,Complete Remission/Response,491.0,0.0
1399,LUSC,62.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Progressive Disease,538.0,0.0
1400,LUSC,67.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,557.0,0.0
1401,LUSC,75.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,531.0,0.0
1402,LUSC,65.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,589.0,0.0
1403,LUSC,78.0,FEMALE,ASIAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,842.0,0.0
1404,LUSC,73.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,652.0,0.0
1405,LUSC,75.0,FEMALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,937.0,0.0
1406,LUSC,70.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,649.0,0.0
1407,LUSC,67.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,826.0,0.0
1408,LUSC,77.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,822.0,0.0
1409,LUSC,64.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,565.0,0.0
1410,LUSC,77.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,630.0,0.0
1411,LUSC,70.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,581.0,0.0
1412,LUSC,71.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,392.0,0.0
1413,LUSC,68.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,401.0,0.0
1414,LUSC,60.0,MALE,WHITE,Stage IIB,2008.0,TUMOR FREE,Complete Remission/Response,2336.0,0.0
1415,LUSC,59.0,MALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,1963.0,0.0
1416,LUSC,53.0,MALE,WHITE,Stage IA,2009.0,TUMOR FREE,Complete Remission/Response,37.0,0.0
1417,LUSC,68.0,FEMALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1743.0,0.0
1418,LUSC,58.0,FEMALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,128.0,0.0
1419,LUSC,76.0,MALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,1212.0,0.0
1420,LUSC,77.0,MALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1499.0,0.0
1421,LUSC,70.0,FEMALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,1336.0,0.0
1422,LUSC,75.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1244.0,0.0
1423,LUSC,69.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Complete Remission/Response,804.0,0.0
1424,LUSC,70.0,MALE,WHITE,Stage IA,2008.0,WITH TUMOR,Stable Disease,1997.0,0.0
1425,LUSC,73.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Stable Disease,111.0,0.0
1426,LUSC,57.0,MALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Progressive Disease,511.0,0.0
1427,LUSC,66.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2013.0,TUMOR FREE,Stable Disease,13.0,0.0
1428,PAAD,48.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,729.0,0.0
1429,PAAD,73.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,676.0,0.0
1430,PAAD,61.0,MALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,1287.0,0.0
1431,PAAD,55.0,FEMALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Progressive Disease,969.0,0.0
1432,PAAD,71.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,484.0,0.0
1433,PAAD,43.0,MALE,WHITE,Stage IIB,2013.0,WITH TUMOR,Progressive Disease,440.0,0.0
1434,PAAD,58.0,FEMALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,463.0,0.0
1435,PAAD,60.0,FEMALE,WHITE,Stage IIA,2013.0,WITH TUMOR,Progressive Disease,438.0,0.0
1436,PAAD,52.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Stable Disease,1383.0,0.0
1437,PAAD,66.0,FEMALE,WHITE,Stage IA,2012.0,WITH TUMOR,Stable Disease,1021.0,0.0
1438,PAAD,65.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1854.0,0.0
1439,PAAD,62.0,FEMALE,WHITE,Stage IB,2008.0,TUMOR FREE,Complete Remission/Response,2084.0,0.0
1440,PAAD,64.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,1542.0,0.0
1441,PAAD,67.0,MALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,998.0,0.0
1442,PAAD,59.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,1103.0,0.0
1443,PAAD,40.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,1037.0,0.0
1444,PAAD,75.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Progressive Disease,743.0,0.0
1445,PAAD,70.0,MALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,295.0,0.0
1446,PAAD,65.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,586.0,0.0
1447,PAAD,76.0,MALE,WHITE,Stage IIA,2013.0,WITH TUMOR,Progressive Disease,517.0,0.0
1448,PAAD,54.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,767.0,0.0
1449,PAAD,54.0,MALE,WHITE,Stage IIB,2008.0,TUMOR FREE,Complete Remission/Response,716.0,0.0
1450,PAAD,56.0,FEMALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Complete Remission/Response,392.0,0.0
1451,PAAD,72.0,MALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Complete Remission/Response,969.0,0.0
1452,PAAD,65.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,314.0,0.0
1453,PAAD,60.0,FEMALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,840.0,0.0
1454,PAAD,69.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Complete Remission/Response,706.0,0.0
1455,PAAD,73.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,454.0,0.0
1456,PAAD,58.0,FEMALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Progressive Disease,660.0,0.0
1457,PAAD,68.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,491.0,0.0
1458,PAAD,72.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Progressive Disease,657.0,0.0
1459,PAAD,77.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,330.0,0.0
1460,PAAD,49.0,FEMALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1116.0,0.0
1461,PAAD,78.0,FEMALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,1257.0,0.0
1462,PAAD,79.0,FEMALE,WHITE,Stage III,2011.0,WITH TUMOR,Partial Remission/Response,462.0,0.0
1463,PAAD,59.0,MALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Complete Remission/Response,522.0,0.0
1464,PAAD,64.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,635.0,0.0
1465,PAAD,63.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Partial Remission/Response,666.0,0.0
1466,PAAD,81.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,483.0,0.0
1467,PAAD,76.0,MALE,WHITE,Stage IIB,2013.0,WITH TUMOR,Partial Remission/Response,8.0,0.0
1468,PAAD,68.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,431.0,0.0
1469,PAAD,67.0,MALE,WHITE,Stage IIB,2013.0,WITH TUMOR,Partial Remission/Response,338.0,0.0
1470,PAAD,65.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,287.0,0.0
1471,PAAD,35.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,245.0,0.0
1472,PAAD,49.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,404.0,0.0
1473,PAAD,43.0,MALE,WHITE,Stage IIB,2013.0,WITH TUMOR,Progressive Disease,286.0,0.0
1474,PAAD,60.0,FEMALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,9.0,0.0
1475,PAAD,67.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,737.0,0.0
1476,PAAD,75.0,FEMALE,WHITE,Stage IIB,2013.0,WITH TUMOR,Complete Remission/Response,525.0,0.0
1477,PAAD,61.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1216.0,0.0
1478,PAAD,56.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,498.0,0.0
1479,PAAD,67.0,MALE,WHITE,Stage IB,2012.0,WITH TUMOR,Progressive Disease,951.0,0.0
1480,PAAD,53.0,FEMALE,WHITE,Stage IB,2012.0,WITH TUMOR,Progressive Disease,720.0,0.0
1481,PAAD,59.0,MALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,350.0,0.0
1482,PAAD,61.0,FEMALE,WHITE,Stage IIB,2009.0,TUMOR FREE,Complete Remission/Response,2016.0,0.0
1483,PAAD,74.0,FEMALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,467.0,0.0
1484,READ,57.0,MALE,WHITE,Stage IIIC,2009.0,TUMOR FREE,Complete Remission/Response,1427.0,0.0
1485,READ,48.0,FEMALE,WHITE,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,1309.0,0.0
1486,READ,48.0,MALE,WHITE,Stage IIIC,2009.0,WITH TUMOR,Complete Remission/Response,1148.0,0.0
1487,READ,39.0,MALE,WHITE,Stage IIIB,2010.0,WITH TUMOR,Complete Remission/Response,1146.0,0.0
1488,READ,77.0,MALE,WHITE,Stage IVA,2010.0,TUMOR FREE,Complete Remission/Response,912.0,0.0
1489,READ,72.0,FEMALE,WHITE,Stage IIIB,2011.0,WITH TUMOR,Progressive Disease,741.0,0.0
1490,READ,66.0,MALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,609.0,0.0
1491,READ,43.0,MALE,WHITE,Stage IV,2011.0,WITH TUMOR,Progressive Disease,748.0,0.0
1492,READ,56.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2006.0,TUMOR FREE,Complete Remission/Response,2635.0,0.0
1493,READ,48.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,2008.0,TUMOR FREE,Complete Remission/Response,2007.0,0.0
1494,READ,47.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,360.0,0.0
1495,READ,48.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,804.0,0.0
1496,READ,46.0,MALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,592.0,0.0
1497,READ,73.0,MALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,646.0,0.0
1498,READ,41.0,FEMALE,WHITE,Stage IVA,2010.0,WITH TUMOR,Progressive Disease,1009.0,0.0
1499,READ,71.0,FEMALE,WHITE,Stage IIIC,2006.0,TUMOR FREE,Complete Remission/Response,2376.0,0.0
1500,READ,90.0,FEMALE,WHITE,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,218.0,0.0
1501,READ,49.0,FEMALE,WHITE,Stage IIIB,2010.0,TUMOR FREE,Complete Remission/Response,639.0,0.0
1502,READ,57.0,MALE,WHITE,Stage I,2010.0,TUMOR FREE,Complete Remission/Response,762.0,0.0
1503,READ,51.0,MALE,ASIAN,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,384.0,0.0
1504,READ,64.0,FEMALE,WHITE,Stage IIA,2010.0,TUMOR FREE,Complete Remission/Response,1506.0,0.0
1505,READ,62.0,FEMALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,1288.0,0.0
1506,READ,71.0,MALE,WHITE,Stage IVA,2010.0,WITH TUMOR,Progressive Disease,452.0,0.0
1507,READ,72.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,979.0,0.0
1508,READ,67.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1110.0,0.0
1509,READ,57.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1131.0,0.0
1510,READ,60.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1160.0,0.0
1511,READ,74.0,FEMALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
1512,STAD,70.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,1765.0,0.0
1513,STAD,51.0,FEMALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,812.0,0.0
1514,STAD,52.0,MALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,595.0,0.0
1515,STAD,74.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,335.0,0.0
1516,STAD,51.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,288.0,0.0
1517,STAD,60.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,287.0,0.0
1518,STAD,78.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1055.0,0.0
1519,STAD,54.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,485.0,0.0
1520,STAD,69.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,416.0,0.0
1521,STAD,60.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1190.0,0.0
1522,STAD,64.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,997.0,0.0
1523,STAD,75.0,MALE,WHITE,Stage IIA,2011.0,WITH TUMOR,Complete Remission/Response,491.0,0.0
1524,STAD,41.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,273.0,0.0
1525,STAD,70.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1223.0,0.0
1526,STAD,65.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,940.0,0.0
1527,STAD,54.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,949.0,0.0
1528,STAD,64.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1367.0,0.0
1529,STAD,64.0,MALE,WHITE,Stage IV,2011.0,WITH TUMOR,Complete Remission/Response,666.0,0.0
1530,STAD,69.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,280.0,0.0
1531,STAD,81.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1100.0,0.0
1532,STAD,69.0,FEMALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,1072.0,0.0
1533,STAD,69.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,1090.0,0.0
1534,STAD,65.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1023.0,0.0
1535,STAD,62.0,FEMALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1210.0,0.0
1536,STAD,74.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,574.0,1.0
1537,STAD,60.0,MALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,899.0,0.0
1538,STAD,59.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,1010.0,0.0
1539,STAD,53.0,FEMALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,1133.0,0.0
1540,STAD,58.0,FEMALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,21.0,0.0
1541,STAD,70.0,FEMALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,900.0,0.0
1542,STAD,71.0,FEMALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,981.0,0.0
1543,STAD,49.0,MALE,WHITE,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,895.0,0.0
1544,STAD,58.0,MALE,WHITE,Stage IIIC,2012.0,WITH TUMOR,Progressive Disease,225.0,0.0
1545,STAD,66.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,188.0,0.0
1546,STAD,71.0,FEMALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,946.0,0.0
1547,STAD,42.0,FEMALE,WHITE,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,675.0,0.0
1548,STAD,80.0,FEMALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,29.0,0.0
1549,STAD,84.0,FEMALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,131.0,0.0
1550,STAD,76.0,FEMALE,WHITE,Stage IIIB,2011.0,WITH TUMOR,Complete Remission/Response,427.0,0.0
1551,STAD,64.0,MALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,101.0,0.0
1552,STAD,63.0,MALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,951.0,0.0
1553,STAD,65.0,FEMALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,450.0,0.0
1554,STAD,55.0,MALE,WHITE,Stage IIIC,2012.0,WITH TUMOR,Complete Remission/Response,21.0,0.0
1555,STAD,51.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,224.0,0.0
1556,STAD,69.0,MALE,WHITE,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,113.0,0.0
1557,STAD,68.0,FEMALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,280.0,0.0
1558,STAD,90.0,FEMALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,615.0,0.0
1559,STAD,64.0,FEMALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,34.0,0.0
1560,STAD,55.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,389.0,0.0
1561,STAD,56.0,MALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,825.0,0.0
1562,STAD,79.0,MALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,856.0,0.0
1563,STAD,59.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,229.0,0.0
1564,STAD,74.0,FEMALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,813.0,0.0
1565,STAD,76.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,754.0,0.0
1566,STAD,63.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,0.0,0.0
1567,STAD,45.0,MALE,ASIAN,Stage IV,2012.0,TUMOR FREE,Complete Remission/Response,972.0,0.0
1568,STAD,52.0,MALE,ASIAN,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,991.0,0.0
1569,STAD,54.0,FEMALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,325.0,0.0
1570,STAD,53.0,FEMALE,WHITE,Stage IIA,2012.0,WITH TUMOR,Complete Remission/Response,1038.0,0.0
1571,STAD,58.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Complete Remission/Response,1064.0,0.0
1572,STAD,70.0,FEMALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,0.0,0.0
1573,STAD,34.0,FEMALE,ASIAN,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,838.0,0.0
1574,STAD,58.0,MALE,ASIAN,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,392.0,0.0
1575,STAD,70.0,MALE,ASIAN,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,431.0,0.0
1576,STAD,56.0,MALE,ASIAN,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,862.0,0.0
1577,STAD,69.0,FEMALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,20.0,0.0
1578,STAD,49.0,MALE,ASIAN,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,989.0,0.0
1579,STAD,71.0,FEMALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,411.0,0.0
1580,STAD,55.0,MALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,14.0,0.0
1581,STAD,72.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,628.0,0.0
1582,STAD,68.0,FEMALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,621.0,0.0
1583,STAD,72.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,35.0,0.0
1584,STAD,65.0,MALE,WHITE,Stage IIIA,2012.0,WITH TUMOR,Complete Remission/Response,156.0,0.0
1585,STAD,82.0,MALE,ASIAN,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,408.0,0.0
1586,STAD,45.0,MALE,ASIAN,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,396.0,0.0
1587,STAD,51.0,FEMALE,ASIAN,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,400.0,0.0
1588,STAD,58.0,MALE,ASIAN,Stage II,2010.0,TUMOR FREE,Complete Remission/Response,406.0,0.0
1589,STAD,61.0,FEMALE,ASIAN,Stage II,2010.0,WITH TUMOR,Complete Remission/Response,388.0,0.0
1590,STAD,82.0,FEMALE,ASIAN,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
1591,STAD,73.0,FEMALE,ASIAN,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,381.0,0.0
1592,STAD,43.0,FEMALE,ASIAN,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,375.0,0.0
1593,STAD,65.0,MALE,ASIAN,Stage IV,2011.0,TUMOR FREE,Complete Remission/Response,374.0,0.0
1594,STAD,51.0,MALE,ASIAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,377.0,0.0
1595,STAD,66.0,FEMALE,ASIAN,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
1596,STAD,48.0,MALE,ASIAN,Stage II,2011.0,WITH TUMOR,Complete Remission/Response,468.0,0.0
1597,STAD,41.0,MALE,ASIAN,Stage II,2011.0,WITH TUMOR,Progressive Disease,367.0,0.0
1598,STAD,59.0,MALE,ASIAN,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,390.0,0.0
1599,STAD,74.0,MALE,ASIAN,Stage II,2011.0,TUMOR FREE,Complete Remission/Response,378.0,0.0
1600,STAD,51.0,MALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,374.0,0.0
1601,STAD,57.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,378.0,0.0
1602,STAD,86.0,FEMALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,371.0,0.0
1603,STAD,60.0,MALE,ASIAN,Stage IB,2011.0,WITH TUMOR,Complete Remission/Response,384.0,0.0
1604,STAD,74.0,MALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,636.0,0.0
1605,STAD,75.0,MALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,582.0,0.0
1606,STAD,53.0,MALE,WHITE,Stage IIIA,2010.0,WITH TUMOR,Progressive Disease,573.0,0.0
1607,STAD,58.0,MALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,566.0,0.0
1608,STAD,53.0,MALE,WHITE,Stage II,2010.0,WITH TUMOR,Progressive Disease,543.0,0.0
1609,STAD,67.0,FEMALE,WHITE,Stage IIIA,2010.0,TUMOR FREE,Complete Remission/Response,523.0,0.0
1610,STAD,70.0,FEMALE,WHITE,Stage IB,2010.0,TUMOR FREE,Complete Remission/Response,463.0,0.0
1611,STAD,70.0,FEMALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Complete Remission/Response,486.0,0.0
1612,STAD,64.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,344.0,0.0
1613,STAD,77.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,375.0,0.0
1614,STAD,44.0,MALE,WHITE,Stage IIIB,2011.0,WITH TUMOR,Complete Remission/Response,752.0,0.0
1615,STAD,57.0,MALE,WHITE,Stage IIB,2012.0,WITH TUMOR,Complete Remission/Response,511.0,0.0
1616,STAD,57.0,MALE,WHITE,Stage IIA,2012.0,WITH TUMOR,Complete Remission/Response,593.0,0.0
1617,STAD,72.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,523.0,0.0
1618,STAD,72.0,MALE,WHITE,Stage IB,2012.0,WITH TUMOR,Complete Remission/Response,643.0,0.0
1619,STAD,66.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,636.0,0.0
1620,STAD,56.0,MALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,434.0,0.0
1621,STAD,73.0,MALE,WHITE,Stage IIIB,2012.0,WITH TUMOR,Stable Disease,500.0,0.0
1622,STAD,63.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,1108.0,0.0
1623,STAD,61.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Stable Disease,419.0,0.0
1624,STAD,60.0,FEMALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,449.0,0.0
1625,STAD,76.0,MALE,WHITE,Stage IIIB,2012.0,WITH TUMOR,Complete Remission/Response,804.0,0.0
1626,STAD,71.0,FEMALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,342.0,0.0
1627,STAD,72.0,FEMALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Complete Remission/Response,344.0,0.0
1628,STAD,79.0,FEMALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,678.0,0.0
1629,STAD,62.0,MALE,WHITE,Stage IB,2012.0,TUMOR FREE,Complete Remission/Response,476.0,0.0
1630,STAD,61.0,FEMALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Complete Remission/Response,607.0,0.0
1631,STAD,70.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,494.0,0.0
1632,STAD,90.0,MALE,BLACK OR AFRICAN AMERICAN,Stage I,2009.0,TUMOR FREE,Complete Remission/Response,200.0,0.0
1633,STAD,79.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,440.0,0.0
1634,STAD,70.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,647.0,0.0
1635,STAD,68.0,MALE,ASIAN,Stage IIA,2013.0,WITH TUMOR,Complete Remission/Response,346.0,0.0
1636,STAD,69.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,594.0,0.0
1637,STAD,77.0,MALE,WHITE,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,678.0,0.0
1638,STAD,79.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,519.0,0.0
1639,STAD,62.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,413.0,0.0
1640,STAD,55.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,337.0,0.0
1641,STAD,77.0,FEMALE,ASIAN,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,742.0,0.0
1642,STAD,72.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,552.0,0.0
1643,STAD,76.0,MALE,ASIAN,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,881.0,0.0
1644,STAD,58.0,FEMALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,679.0,0.0
1645,STAD,82.0,FEMALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,694.0,0.0
1646,STAD,70.0,MALE,ASIAN,Stage IIIB,2012.0,WITH TUMOR,Complete Remission/Response,641.0,0.0
1647,STAD,75.0,MALE,ASIAN,Stage IA,2012.0,TUMOR FREE,Stable Disease,23.0,0.0
1648,STAD,45.0,MALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,739.0,0.0
1649,STAD,54.0,MALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Stable Disease,170.0,0.0
1650,STAD,74.0,MALE,ASIAN,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,738.0,0.0
1651,STAD,71.0,FEMALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,690.0,0.0
1652,STAD,67.0,FEMALE,ASIAN,Stage IA,2011.0,TUMOR FREE,Stable Disease,736.0,0.0
1653,STAD,74.0,MALE,ASIAN,Stage IIIB,2011.0,TUMOR FREE,Stable Disease,99.0,0.0
1654,STAD,56.0,MALE,ASIAN,Stage IIB,2011.0,WITH TUMOR,Progressive Disease,692.0,0.0
1655,STAD,69.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,785.0,0.0
1656,STAD,75.0,MALE,ASIAN,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,358.0,0.0
1657,STAD,60.0,FEMALE,ASIAN,Stage IIIC,2011.0,WITH TUMOR,Progressive Disease,650.0,0.0
1658,STAD,61.0,MALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,912.0,0.0
1659,STAD,62.0,FEMALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,273.0,0.0
1660,STAD,71.0,FEMALE,ASIAN,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,198.0,0.0
1661,STAD,73.0,MALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,200.0,0.0
1662,STAD,70.0,FEMALE,ASIAN,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,616.0,0.0
1663,STAD,76.0,FEMALE,ASIAN,Stage IIIA,2012.0,TUMOR FREE,Stable Disease,8.0,0.0
1664,STAD,72.0,MALE,ASIAN,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,64.0,0.0
1665,STAD,58.0,FEMALE,ASIAN,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,394.0,0.0
1666,STAD,56.0,FEMALE,ASIAN,Stage IIIC,2011.0,WITH TUMOR,Progressive Disease,882.0,0.0
1667,STAD,53.0,FEMALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,725.0,0.0
1668,STAD,71.0,MALE,ASIAN,Stage IB,2011.0,TUMOR FREE,Complete Remission/Response,724.0,0.0
1669,STAD,72.0,FEMALE,ASIAN,Stage IIIA,2011.0,WITH TUMOR,Complete Remission/Response,644.0,0.0
1670,STAD,77.0,MALE,ASIAN,Stage IB,2012.0,WITH TUMOR,Complete Remission/Response,428.0,0.0
1671,STAD,73.0,MALE,ASIAN,Stage IIIA,2010.0,TUMOR FREE,Stable Disease,1016.0,0.0
1672,STAD,50.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1106.0,0.0
1673,STAD,80.0,MALE,WHITE,Stage IIB,2011.0,WITH TUMOR,Progressive Disease,572.0,0.0
1674,STAD,45.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,Complete Remission/Response,559.0,0.0
1675,STAD,64.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,379.0,0.0
1676,STAD,72.0,FEMALE,WHITE,Stage IIA,2012.0,TUMOR FREE,Complete Remission/Response,594.0,0.0
1677,STAD,76.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,383.0,0.0
1678,STAD,64.0,FEMALE,WHITE,Stage IV,2013.0,TUMOR FREE,Complete Remission/Response,198.0,0.0
1679,STAD,73.0,FEMALE,WHITE,Stage IIB,2013.0,TUMOR FREE,Complete Remission/Response,323.0,0.0
1680,STAD,69.0,MALE,WHITE,Stage IIIB,2013.0,WITH TUMOR,Progressive Disease,356.0,0.0
1681,STAD,63.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,479.0,0.0
1682,STAD,78.0,FEMALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,411.0,0.0
1683,STAD,68.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,613.0,0.0
1684,STAD,79.0,FEMALE,ASIAN,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1145.0,0.0
1685,STAD,86.0,FEMALE,WHITE,Stage IIIA,2012.0,TUMOR FREE,Complete Remission/Response,600.0,0.0
1686,STAD,61.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Stable Disease,427.0,0.0
1687,STAD,51.0,MALE,WHITE,Stage IV,2010.0,TUMOR FREE,Complete Remission/Response,1389.0,0.0
1688,STAD,44.0,FEMALE,WHITE,Stage IV,2009.0,TUMOR FREE,Complete Remission/Response,2267.0,0.0
1689,STAD,56.0,MALE,WHITE,Stage IIIB,2001.0,TUMOR FREE,Complete Remission/Response,3720.0,0.0
1690,STAD,72.0,MALE,WHITE,Stage IIIB,2004.0,WITH TUMOR,Complete Remission/Response,1153.0,1.0
1691,STAD,53.0,FEMALE,WHITE,Stage IIIB,2006.0,TUMOR FREE,Complete Remission/Response,1236.0,0.0
1692,STAD,70.0,MALE,WHITE,Stage IIIB,2001.0,TUMOR FREE,Complete Remission/Response,3519.0,0.0
1693,STAD,59.0,FEMALE,WHITE,Stage IB,2002.0,TUMOR FREE,Complete Remission/Response,3540.0,0.0
1694,STAD,58.0,FEMALE,WHITE,Stage IIIA,2006.0,TUMOR FREE,Complete Remission/Response,2171.0,0.0
1695,STAD,63.0,FEMALE,ASIAN,Stage II,2009.0,TUMOR FREE,Complete Remission/Response,1083.0,0.0
1696,STAD,61.0,FEMALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,579.0,0.0
1697,STAD,45.0,MALE,WHITE,Stage IIIA,2013.0,TUMOR FREE,Progressive Disease,176.0,0.0
1698,STAD,57.0,MALE,ASIAN,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,1319.0,0.0
1699,STAD,59.0,MALE,WHITE,Stage IV,2012.0,WITH TUMOR,Stable Disease,1138.0,0.0
1700,STAD,68.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,1160.0,0.0
1701,STAD,72.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,1132.0,0.0
1702,STAD,72.0,FEMALE,BLACK OR AFRICAN AMERICAN,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,942.0,0.0
1703,STAD,65.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,900.0,0.0
1704,STAD,56.0,FEMALE,WHITE,Stage II,2008.0,TUMOR FREE,Complete Remission/Response,2233.0,0.0
1705,STAD,67.0,MALE,WHITE,Stage IIIB,2011.0,TUMOR FREE,Complete Remission/Response,1200.0,0.0
1706,STAD,67.0,FEMALE,WHITE,Stage IIIB,2013.0,TUMOR FREE,Complete Remission/Response,664.0,0.0
1707,STAD,69.0,MALE,WHITE,Stage IIIA,2009.0,TUMOR FREE,Complete Remission/Response,1862.0,0.0
1708,STAD,63.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,1000.0,0.0
1709,STAD,67.0,FEMALE,WHITE,Stage IIIA,2010.0,WITH TUMOR,Complete Remission/Response,1690.0,0.0
1710,STAD,67.0,MALE,WHITE,Stage IB,2009.0,TUMOR FREE,Complete Remission/Response,2032.0,0.0
1711,STAD,70.0,MALE,WHITE,Stage IIB,2012.0,TUMOR FREE,Complete Remission/Response,819.0,0.0
1712,STAD,52.0,FEMALE,WHITE,Stage IIIC,2011.0,TUMOR FREE,Complete Remission/Response,1328.0,0.0
1713,STAD,35.0,MALE,WHITE,Stage IIIA,2011.0,TUMOR FREE,Complete Remission/Response,864.0,0.0
1714,STAD,56.0,MALE,WHITE,Stage IIIC,2012.0,TUMOR FREE,Complete Remission/Response,1184.0,0.0
1715,STAD,48.0,MALE,WHITE,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,1002.0,0.0
1716,STAD,57.0,MALE,WHITE,Stage IIB,2010.0,TUMOR FREE,Progressive Disease,1646.0,0.0
1717,STAD,75.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIB,2012.0,TUMOR FREE,Complete Remission/Response,838.0,0.0
1718,STAD,71.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,525.0,0.0
1719,TGCT,38.0,MALE,WHITE,IS,2011.0,TUMOR FREE,Complete Remission/Response,1259.0,0.0
1720,TGCT,28.0,MALE,ASIAN,IS,2011.0,TUMOR FREE,Complete Remission/Response,1403.0,0.0
1721,TGCT,30.0,MALE,WHITE,Stage I,2008.0,TUMOR FREE,Complete Remission/Response,2315.0,0.0
1722,TGCT,28.0,MALE,WHITE,IS,2005.0,TUMOR FREE,Complete Remission/Response,3491.0,0.0
1723,TGCT,33.0,MALE,WHITE,Stage IA,2004.0,TUMOR FREE,Complete Remission/Response,3911.0,0.0
1724,TGCT,37.0,MALE,WHITE,Stage IIA,2001.0,TUMOR FREE,Complete Remission/Response,4702.0,0.0
1725,TGCT,30.0,MALE,WHITE,IS,1998.0,TUMOR FREE,Complete Remission/Response,6183.0,0.0
1726,TGCT,38.0,MALE,WHITE,Stage IIB,2011.0,TUMOR FREE,Complete Remission/Response,1375.0,0.0
1727,TGCT,41.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,675.0,0.0
1728,TGCT,35.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,750.0,0.0
1729,TGCT,31.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,503.0,0.0
1730,TGCT,26.0,MALE,WHITE,Stage IIIB,2013.0,TUMOR FREE,Complete Remission/Response,773.0,0.0
1731,TGCT,33.0,MALE,WHITE,Stage IIA,2013.0,TUMOR FREE,Complete Remission/Response,685.0,0.0
1732,TGCT,31.0,MALE,WHITE,IS,2011.0,TUMOR FREE,Complete Remission/Response,1389.0,0.0
1733,TGCT,24.0,MALE,WHITE,Stage IIA,2011.0,TUMOR FREE,Complete Remission/Response,1099.0,0.0
1734,TGCT,32.0,MALE,WHITE,Stage III,2011.0,TUMOR FREE,Partial Remission/Response,1353.0,0.0
1735,TGCT,23.0,MALE,WHITE,IS,2010.0,TUMOR FREE,Complete Remission/Response,1529.0,0.0
1736,TGCT,53.0,MALE,WHITE,IS,2009.0,TUMOR FREE,Complete Remission/Response,1593.0,0.0
1737,TGCT,36.0,MALE,WHITE,IS,2008.0,TUMOR FREE,Complete Remission/Response,2299.0,0.0
1738,TGCT,24.0,MALE,WHITE,IS,2008.0,TUMOR FREE,Complete Remission/Response,2231.0,0.0
1739,TGCT,33.0,MALE,WHITE,IS,2008.0,TUMOR FREE,Complete Remission/Response,2475.0,0.0
1740,TGCT,21.0,MALE,WHITE,Stage IB,2008.0,TUMOR FREE,Complete Remission/Response,2289.0,0.0
1741,TGCT,25.0,MALE,WHITE,Stage IIIB,2008.0,TUMOR FREE,Partial Remission/Response,2234.0,0.0
1742,TGCT,38.0,MALE,WHITE,Stage IIA,2008.0,TUMOR FREE,Complete Remission/Response,2439.0,0.0
1743,TGCT,28.0,MALE,WHITE,IS,2007.0,TUMOR FREE,Complete Remission/Response,2585.0,0.0
1744,TGCT,21.0,MALE,WHITE,IS,2007.0,TUMOR FREE,Complete Remission/Response,2478.0,0.0
1745,TGCT,28.0,MALE,WHITE,IS,2007.0,TUMOR FREE,Complete Remission/Response,2734.0,0.0
1746,TGCT,20.0,MALE,WHITE,Stage IIIC,2007.0,TUMOR FREE,Partial Remission/Response,2611.0,0.0
1747,TGCT,33.0,MALE,WHITE,IS,2006.0,TUMOR FREE,Complete Remission/Response,3137.0,0.0
1748,TGCT,28.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IA,2006.0,TUMOR FREE,Complete Remission/Response,2938.0,0.0
1749,TGCT,20.0,MALE,WHITE,IS,2005.0,TUMOR FREE,Complete Remission/Response,3621.0,0.0
1750,TGCT,51.0,MALE,WHITE,IS,2004.0,TUMOR FREE,Partial Remission/Response,3891.0,0.0
1751,TGCT,41.0,MALE,WHITE,Stage IIIB,2004.0,TUMOR FREE,Partial Remission/Response,3656.0,0.0
1752,TGCT,41.0,MALE,WHITE,IS,2003.0,TUMOR FREE,Partial Remission/Response,4026.0,0.0
1753,TGCT,33.0,MALE,WHITE,Stage IIA,2003.0,TUMOR FREE,Complete Remission/Response,4018.0,0.0
1754,TGCT,39.0,MALE,WHITE,Stage IIIB,2001.0,TUMOR FREE,Complete Remission/Response,4816.0,0.0
1755,TGCT,30.0,MALE,WHITE,IS,2002.0,TUMOR FREE,Complete Remission/Response,4406.0,0.0
1756,TGCT,38.0,MALE,WHITE,IS,2001.0,TUMOR FREE,Complete Remission/Response,4899.0,0.0
1757,TGCT,22.0,MALE,WHITE,Stage IA,2000.0,TUMOR FREE,Complete Remission/Response,5514.0,0.0
1758,TGCT,28.0,MALE,WHITE,IS,2000.0,TUMOR FREE,Complete Remission/Response,5329.0,0.0
1759,TGCT,27.0,MALE,WHITE,Stage IIIA,2000.0,TUMOR FREE,Partial Remission/Response,5233.0,0.0
1760,TGCT,30.0,MALE,WHITE,IS,1999.0,TUMOR FREE,Complete Remission/Response,5477.0,0.0
1761,TGCT,20.0,MALE,WHITE,IS,1998.0,TUMOR FREE,Complete Remission/Response,6060.0,0.0
1762,TGCT,20.0,MALE,WHITE,Stage I,1997.0,TUMOR FREE,Complete Remission/Response,1822.0,0.0
1763,TGCT,34.0,MALE,WHITE,Stage II,1997.0,TUMOR FREE,Partial Remission/Response,6210.0,0.0
1764,TGCT,45.0,MALE,WHITE,Stage IIIC,2008.0,TUMOR FREE,Partial Remission/Response,2248.0,0.0
1765,TGCT,48.0,MALE,WHITE,Stage IB,2005.0,TUMOR FREE,Partial Remission/Response,3349.0,0.0
1766,TGCT,33.0,MALE,WHITE,IS,1999.0,TUMOR FREE,Complete Remission/Response,5539.0,0.0
1767,TGCT,25.0,MALE,WHITE,Stage I,1992.0,TUMOR FREE,Complete Remission/Response,1819.0,0.0
1768,TGCT,26.0,MALE,WHITE,Stage I,1994.0,TUMOR FREE,Complete Remission/Response,7081.0,0.0
1769,TGCT,32.0,MALE,WHITE,Stage I,1996.0,TUMOR FREE,Complete Remission/Response,6445.0,0.0
1770,TGCT,31.0,MALE,WHITE,IS,1999.0,TUMOR FREE,Complete Remission/Response,5667.0,0.0
1771,TGCT,32.0,MALE,WHITE,IS,2013.0,TUMOR FREE,Complete Remission/Response,542.0,0.0
1772,TGCT,18.0,MALE,WHITE,Stage III,1997.0,TUMOR FREE,Partial Remission/Response,6340.0,0.0
1773,TGCT,22.0,MALE,WHITE,Stage I,1996.0,TUMOR FREE,Complete Remission/Response,6598.0,0.0
1774,TGCT,19.0,MALE,WHITE,Stage II,1996.0,TUMOR FREE,Complete Remission/Response,6862.0,0.0
1775,TGCT,26.0,MALE,WHITE,Stage II,1995.0,TUMOR FREE,Partial Remission/Response,7023.0,0.0
1776,TGCT,31.0,MALE,WHITE,Stage I,1994.0,TUMOR FREE,Complete Remission/Response,7437.0,0.0
1777,TGCT,32.0,MALE,WHITE,IS,2003.0,TUMOR FREE,Complete Remission/Response,3991.0,0.0
1778,TGCT,43.0,MALE,WHITE,Stage IIIB,2007.0,TUMOR FREE,Partial Remission/Response,2645.0,0.0
1779,TGCT,49.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,435.0,0.0
1780,TGCT,42.0,MALE,WHITE,Stage I,2013.0,WITH TUMOR,No Measureable Tumor or Tumor Markers,607.0,0.0
1781,TGCT,34.0,MALE,WHITE,IS,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,436.0,0.0
1782,TGCT,26.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,518.0,0.0
1783,TGCT,31.0,MALE,WHITE,IS,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,483.0,0.0
1784,TGCT,37.0,MALE,WHITE,IS,2013.0,TUMOR FREE,Complete Remission/Response,698.0,0.0
1785,TGCT,27.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,Complete Remission/Response,552.0,0.0
1786,TGCT,22.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,Complete Remission/Response,413.0,0.0
1787,TGCT,26.0,MALE,WHITE,IS,2013.0,TUMOR FREE,Complete Remission/Response,496.0,0.0
1788,TGCT,30.0,MALE,WHITE,IS,2013.0,TUMOR FREE,Complete Remission/Response,293.0,0.0
1789,TGCT,21.0,MALE,WHITE,IS,2013.0,TUMOR FREE,Complete Remission/Response,312.0,0.0
1790,TGCT,18.0,MALE,WHITE,IS,2013.0,WITH TUMOR,Progressive Disease,524.0,0.0
1791,TGCT,29.0,MALE,WHITE,Stage I,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,540.0,0.0
1792,TGCT,18.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1131.0,0.0
1793,TGCT,31.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1119.0,0.0
1794,TGCT,51.0,MALE,WHITE,Stage I,2011.0,TUMOR FREE,Complete Remission/Response,1146.0,0.0
1795,TGCT,29.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,Complete Remission/Response,1083.0,0.0
1796,TGCT,36.0,MALE,WHITE,Stage IB,2011.0,WITH TUMOR,Complete Remission/Response,1006.0,0.0
1797,TGCT,39.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,727.0,0.0
1798,TGCT,20.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,753.0,0.0
1799,TGCT,28.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,894.0,0.0
1800,TGCT,27.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,1061.0,0.0
1801,TGCT,24.0,MALE,WHITE,IS,2009.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,209.0,0.0
1802,TGCT,23.0,MALE,WHITE,Stage IA,2008.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,559.0,0.0
1803,TGCT,35.0,MALE,WHITE,Stage IA,2008.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,708.0,0.0
1804,TGCT,37.0,MALE,WHITE,IS,2007.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,1041.0,0.0
1805,TGCT,39.0,MALE,WHITE,IS,2007.0,TUMOR FREE,"Normalization of Tumor Markers, but Residual Tumor Mass",2007.0,0.0
1806,TGCT,40.0,MALE,WHITE,Stage IA,2006.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,367.0,0.0
1807,TGCT,47.0,MALE,WHITE,Stage IA,2007.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,240.0,0.0
1808,TGCT,31.0,MALE,WHITE,Stage IA,2008.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,270.0,0.0
1809,TGCT,39.0,MALE,WHITE,Stage IB,2008.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,2058.0,0.0
1810,TGCT,50.0,MALE,ASIAN,Stage IA,2009.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,1268.0,0.0
1811,TGCT,24.0,MALE,WHITE,IS,2009.0,TUMOR FREE,"Normalization of Tumor Markers, but Residual Tumor Mass",1550.0,0.0
1812,TGCT,35.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,471.0,0.0
1813,TGCT,67.0,MALE,WHITE,Stage I,2012.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,672.0,0.0
1814,TGCT,24.0,MALE,WHITE,IS,2012.0,TUMOR FREE,Complete Remission/Response,843.0,0.0
1815,TGCT,37.0,MALE,WHITE,IS,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,281.0,0.0
1816,TGCT,25.0,MALE,WHITE,Stage IA,2009.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,2069.0,0.0
1817,TGCT,45.0,MALE,WHITE,Stage IA,2011.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,1113.0,0.0
1818,TGCT,34.0,MALE,BLACK OR AFRICAN AMERICAN,Stage IIIC,2012.0,WITH TUMOR,"Normalization of Tumor Markers, but Residual Tumor Mass",866.0,0.0
1819,TGCT,29.0,MALE,WHITE,IS,2011.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,864.0,0.0
1820,TGCT,36.0,MALE,WHITE,Stage IIC,2011.0,TUMOR FREE,Complete Remission/Response,1126.0,0.0
1821,TGCT,45.0,MALE,WHITE,Stage IB,2011.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,1498.0,0.0
1822,TGCT,32.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,Complete Remission/Response,838.0,0.0
1823,TGCT,34.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,848.0,0.0
1824,TGCT,39.0,MALE,WHITE,Stage IA,2012.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,811.0,0.0
1825,TGCT,35.0,MALE,WHITE,Stage IA,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,681.0,0.0
1826,TGCT,50.0,MALE,WHITE,IS,2010.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,1736.0,0.0
1827,TGCT,44.0,MALE,WHITE,Stage IB,2013.0,TUMOR FREE,No Measureable Tumor or Tumor Markers,634.0,0.0
